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Abstract  
This study aimed to combine the principles of crystal engineering with the properties of 
cyclotriphosphazene derivatives to construct supramolecular assemblies in the solid state. 
The ease with which the chloro substituents on cyclotriphosphazenes can be replaced 
makes them ideal candidates for this study. The substituents were chosen for their ability 
to form either hydrogen bonding interactions or halogen bonding interactions in the solid 
state. The cyclotriphosphazene derivatives were co-crystallised with various small organic 
molecules with complementary functional groups, as well as with other cyclophosphazene 
derivatives. The aim was to form co-crystals or solvates with these cyclophosphazene 
derivatives as co-crystals contain a wealth of information regarding the forces governing 
the aggregation of molecules in the solid state. Cyclotriphosphazenes, with their array of 
substituents, could broaden the range of potential interactions governing crystalline 
assembly. 
Fifteen cyclotriphosphazene derivatives were synthesised and characterised in this study. 
The novel crystal structures of two cyclotriphosphazene derivatives have been elucidated 
by single crystal X-ray diffraction. These are 2,2-bis(4-formylphenoxy)-4,4,6,6-
bis[spiro(2,2-dioxy-1,1-biphenylyl)]cyclotriphosphazene and hexakis(4-cyano-
phenoxy)cyclotriphosphazene. 
In the course of this study two novel polymorphs of hexakis(4-fluorophenoxy)cyclotri-
phosphazene were identified and studied. The novel triclinic form undergoes an 
irreversible transformation to the previously reported monoclinic phase at high 
temperatures. The reported monoclinic phase, however, transforms to a monoclinic C 
phase in a single-crystal to single-crystal fashion. It is also suspected that this phase 
transformation is in fact reversible on cooling of the crystal to temperatures below -45 °C. 
One novel co-crystal structure of hexakis(4-pyridyloxy)cyclotriphosphazene with 
terephthalic acid was identified and characterised. However, analysis of the Cambridge 
Structural Database indicates that co-crystal formation with cyclophosphazenes is not a 
commonly occurring phenomenon. This leads to the conclusion that cyclotriphosphazenes 
can be used in crystal engineering as supramolecular building blocks, but their shape and 
size tend to inhibit the formation of co-crystals. Therefore co-crystal formers have to be 
chosen with great care. 
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Opsomming 
Die doel van hierdie studie was om die beginsels van kristalingenieurswese te kombineer 
met die eienskappe van siklotrifosfaseen afgeleides om sodoende supramolekulêre 
versamelings in die vastetoestand te bou. Die gemak waarmee die chloor substituente op 
die siklotrifosfaseenring vervang kan word, maak hierdie molekules ideaal vir hierdie 
studie. Die substituente is gekies op grond van hul potensiaal om waterstofbindings of 
intermolekulêre halogeenbindings in die vastetoestand te vorm. Ko-kristallisasie 
eksperimente is met die siklotrifosfaseen afgeleides en verskeie klein organiese molekules 
met komplementêre funksionele groepe uitgevoer, asook tussen die verskeie 
siklotrifosfaseen afgeleides met mekaar. Die doel was om mede-kristalle of solvate met 
hierdie siklotrifosfaseen afgeleides te vorm aangesien mede-kristalle ‘n magdom inligting 
bevat rakende die kragte wat die versameling van molekules in die vaste fase beheer. Die 
siklotrifosfaseen afgeleides wat ‘n wye verskeidenheid substituente kan dra, kan hierdeur 
die moontlike intermolekulêre interaksies wat die versameling in die kristallyne vaste fase 
beheer verbreed. 
In hierdie studie is vyftien siklotrifosfaseen afgeleides gesintetiseer en gekarakteriseer. 
Die voorheen onbekende kristalstrukture van twee siklotrifosfaseen afgeleides is in hierdie 
studie geïdentifiseer, naamlik 2,2-bis(4-formielfenoksie)-4,4,6,6-bis[spiro(2,2-dioksie-
1,1-bifeniliel)]siklotrifosfaseen en heksa(4-sianofenoksie)siklotrifosfaseen. Die strukture 
is bepaal deur enkelkristal X-straaldiffraksie.  
In die loop van hierdie studie is twee voorheen onbekende polimorfs van heksa(4-
fluorofenoksie)siklotrifosfaseen geïdentifiseer en bestudeer. Die nuwe trikliniese vorm 
ondergaan ‘n onomkeerbare faseverandering na die monokliniese vorm by hoë 
temperature. Die bekende monokliniese P fase ondergaan egter ‘n verdere faseverandering 
na ‘n monokliniese C fase. Hierdie geskied as ‘n enkel-kristal na ‘n enkel-kristal 
faseverandering. Daar word ook gespekuleer dat hierdie spesifieke faseverandering wel 
omkeerbaar is indien die kristal na -45 °C afgekoel word. 
Een nuwe mede-kristal tussen heksa(4-pyridieloksie)sikotrifosfaseen en 1,3-dibensoësuur 
is in hierdie studie geïdentifiseer en gekarakteriseer. ‘n Analise van die Cambridge 
Strukturele Databasis het egter aangedui dat die vorming van mede-kristalle nie ‘n 
alledaagse verskynsel is in sikotrifosfaseen afgeleides nie. Dit lei tot die gevolgtrekking 
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dat sikotrifosfaseen molekules wel in kristalingenieurswese gebruik kan word as 
supramolekulêre boustene, maar dat die vorm en grootte van die molekules die 
kristallisering van mede-kristalle verhoed. Dus moet die molekules wat saam met die 
siklotrifosfaseen molekules gekristalliseer wil word, goed deurdink word. 
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Chapter 1   
Introduction  
This study aims to use the principles of crystal engineering to organise 
cyclotriphosphazene derivatives into supramolecular architectures. This introduction will 
highlight certain aspects of the field of supramolecular chemistry to better understand the 
scope of this study. Key concepts used in this study will be explained, of which the first is 
the chemistry and reactivity of cyclotriphosphazenes. This relates to why 
cyclotriphosphazenes were chosen as the building blocks for this study. The term 
supramolecular chemistry will be introduced, with a specific focus on crystal engineering. 
In crystal engineering tailor-made molecules are used to study the effect on the packing in 
the solid state and to what extent it can be controlled and directed. This project serves as a 
further investigation into the potential use of cyclotriphosphazenes in this research niche.  
1.1 Cyclotriphosphazenes 
1.1.1 Chemistry and reactivity 
Phosphazenes are formally unsaturated compounds containing alternating phosphorus-
nitrogen bonds.
1
 They can be classified as monophosphazenes, diphosphazenes, 
polyphosphazenes and cyclophosphazenes. This project focuses on the derivatives and 
supramolecular assemblies of the cyclotriphosphazenes – more specifically the 
phosphonitrilic chloride trimer (Figure 1.1).
2, 3
 The trimer comprises a planar six-
membered ring of alternating phosphorus and nitrogen atoms. 
 
 
 
 
N
P
N
P
N
P
Cl Cl
Cl
ClCl
Cl
(a) (b) (c) 
Figure 1.1 (a) and (b) Structure of the phosphonitrilic chloride trimer where the phosphorus atoms are 
green and the nitrogen atoms are blue. (c) Packing arrangement of phosphonitrilic chloride trimer in the 
solid state. 
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The nitrogen atoms in N3P3Cl6 are sp
2
 hybridised and the phosphorus atoms are 
approximately sp
3
 hybridised.
4
 The bonding involved in the ring has been the cause of 
some debate in the past few years.
5
 In benzene there is extensive electron delocalisation 
due to pπ-pπ bonding,
1
 but in the cyclotriphosphazene system there is the possibility of pπ-
dπ interaction. The lone pair electrons on the nitrogen reside in a sp
2
 orbital in the plane of 
the ring with the remaining electrons occupying the other two sp
2
 orbitals and a pz orbital 
(Figure 1.2a).
1
 One theory is that the pz orbital on the nitrogen atom can interact with the 
dxz or dyz orbital on the phosphorus atom.
6
 This out-of-plane interaction can lead to 
heteromorphic (N-P) pπ-dπ bonding (Figure 1.2b), or homomorphic (N-N) pπ-pπ bonding 
(Figure 1.2c).
1
 This mismatch of the orbitals causes a node to form on every phosphorus 
atom, making the delocalised molecular orbital less stable.
4
 This could possibly explain 
why the cyclotriphosphazenes do not have true aromatic character. 
 
 
 
 
 
 
 
 
 
 
 
 
a) 
b) c) 
Figure 1.2 Adapted from reference 1, Greenwood & Earnshaw, Chemistry of the elements. Orbital diagrams 
representing the bonding in the cyclotriphosphazene ring.
1
 (a) The lone pair electrons of the nitrogen reside in the 
sp
2
 orbital in the plane of the ring. (b) Heteromorphic (N-P) pπ-dπ bonding. (c) Homomorphic (N-N) pπ-pπ 
bonding. 
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The chloro substituents on N3P3Cl6 can be easily replaced by a wide range of functional 
groups. Substitution can take place via two pathways: either geminal or non-geminal 
substitution.
5
 Geminal substitution involves the replacement of two chlorine atoms on the 
same phosphorus, whereas with non-geminal substitution two chlorine atoms on different 
phosphorus atoms are replaced. The type of substitution is determined by the nature of the 
functional group. When the substituent is more electronegative, it polarizes the 
phosphorus-nitrogen bond, activating the phosphorus atom and causing the second 
substituent to bond to the same phosphorus atom. Generally small electronegative 
substituents favour geminal substitution. Non-geminal substitution is mostly favoured by 
larger electron-rich substituents. Non-geminal substitution can also give cis and trans 
isomers – the substituents point either up or down. These two pathways are however not 
exclusively followed and in some cases a mixture of products is obtained – containing 
products of both geminal and non-geminal substitution. This effect only becomes 
significant when products that are not fully substituted are desired.  
1.1.2 31P nuclear magnetic resonance spectroscopy (31P NMR) 
Nuclear magnetic resonance (NMR) is a spectroscopic method that is invaluable in the 
characterisation of molecules. It is also a relatively easy and reliable method of analysing 
the products of a reaction and to ensure purity of the product. 
1
H and 
13
C NMR is often 
used to elucidate the structure of a compound. The 
31
P nucleus has numerous convenient 
NMR properties that make it ideal for Fourier transform (FT) NMR. Two of these 
properties are its spin quantum number of ½ and the fact that it occurs in 100% natural 
abundance.
7, 8
 The 
31
P solution NMR done in this study exclusively measured 
1
H 
decoupled spectra, as this simplifies the interpretation of the data. The phosphorus atoms 
of cyclotriphosphazenes couple to each other, resulting in characteristic peaks depending 
on the level of substitution of the phosphorus atoms, as well as the conformation of the 
ring.
9
 In the case of the phosphonitrilic chloride trimer used in this study, the ring is nearly 
planar. Therefore all the phosphorus atoms are equivalent and only one signal will be seen 
in the 
31
P spectrum.
9
 When the chloro substituents are replaced with other substituents, the 
phosphorus atoms in the ring are no longer equivalent. This causes the appearance of 
doublets, doublets of doublets (dd) or triplets in the spectrum as the phosphorus atoms 
couple to each other. Once all the chloro substituents are replaced with the same 
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substituent, the phosphorus atoms are once again equivalent and only a singlet is seen in 
the spectrum. The level of substitution of the cyclotriphosphazene can therefore be closely 
monitored by 
31
P NMR. 
1.2 Supramolecular chemistry 
It is very difficult to assign a definition to a field that has expanded so much in recent 
years. It is an ever-changing field of science where researchers tend to have their own 
understanding of the terminology used.
10
 In his Nobel lecture
11
, Jean-Marie Lehn defined 
the field as follows: 
“Supramolecular chemistry is the chemistry of the intermolecular bond, covering the 
structures and functions of the entities formed by association of two or more chemical 
species.” 
This means that, broadly, supramolecules are combinations of molecules that come 
together either spontaneously or by design, to form a larger unit with properties resulting 
from the original components. Supramolecular chemistry is the umbrella term for 
describing the study of systems „beyond the molecule‟.12 Braga13 stated it so eloquently 
when he said that “…Supramolecular chemistry has dissolved all the traditional barriers 
between the subdivisions of chemistry…focusing attention on the collective properties…”. 
That is essentially what supramolecular chemists do: they use their knowledge from 
different areas of chemistry to design molecular assemblies in order to study the properties 
of these compounds for possible practical application. When these methods are 
specifically applied to crystalline solids, it leads to the area of crystal engineering.
13
 
1.3 Crystal engineering 
In crystal engineering the aim is to understand crystal packing with regard to 
intermolecular interactions, and then to use this information to design new materials with 
specific physical and chemical properties.
14
 Or, more simply put, it is the making of 
crystals by design.
13
  
The phrase „crystal engineering‟ was first coined by Pepinsky15 in 1955 and has been used 
ever since, as it is a rather accurate description of what it is that chemists do in this field. 
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The first step in crystal engineering is studying the packing arrangement of a crystal in 
order to understand the intermolecular interactions that are responsible for the specific 
arrangement of the molecules.
16
 This is needed to develop a design strategy. When these 
two concepts are understood, the physical and chemical properties can be studied as well 
as the effect that variation in the packing has on the properties of the material. Aakeröy 
described crystal engineering as being “defined by nature and structural consequences of 
intermolecular forces, and the way in which such interactions are utilised for controlling 
the assembly of molecular building blocks into infinite architectures”.17 The key focus of 
crystal engineering is to develop reliable methods with the aim to create molecular 
materials with specific properties that can be fine-tuned according to the crystal engineer‟s 
desire. If for instance, the aim is to design a material with nonlinear optical properties,
18, 19
 
the molecules must arrange in a noncentrosymmetric way with their dipole moments 
aligned.
20
 If the goal is to design a porous material, the molecules must have a sufficiently 
awkward shape to prohibit efficient packing, resulting in solvent-filled voids or channels 
in the crystal structure. The crystal engineering of materials is therefore dependent on the 
interactions at play in the structures. Just as houses are made from brick and cement, 
crystal structures are made of building blocks where the molecules are the bricks and the 
intermolecular interactions serve as the cement holding the structure together and directing 
assembly. 
1.4 Supramolecular synthons 
In crystal engineering it is essential to identify patterns regarding the intermolecular 
interactions guiding the solid-state structure of crystals and therefore it is necessary to find 
reliable substructural units that regularly occur in crystal structures.
21
 Desiraju was the 
first to define the term supramolecular synthon as “structural units within supermolecules 
which can be formed and/or assembled by known or conceivable synthetic operations 
involving intermolecular interactions”.21, 22 A synthon is therefore derived from designed 
combinations of interactions.
21
 This is illustrated in Figure 1.3. The carboxylic acid moiety 
hydrogen bonds to the complementary carboxylic acid moiety of another molecule to form 
the well-known carboxylic acid dimer.
23
 This spatial arrangement of an intermolecular 
interaction is termed a supramolecular synthon.
24
 These supramolecular synthons are 
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dependent on the types of intermolecular interactions that occur in the solid state. Figure 
1.4 illustrates a selection of other supramolecular synthons. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NO H
N
O
H
N
N
H
O
N
H
O
N
H
O
O
H
Figure 1.4 Selected supramolecular synthons, adapted from Aakeröy & Salmon, 
CrystEngComm
34
 and Desiraju, Angew. Chem.
21 
O
OH
molecule 
O
OH
functional group 
synthon 
O
O H O
OH
Figure 1.3 This figure illustrates the concept of a supramolecular synthon, adapted 
from Desiraju, Crystal engineering, from molecules to materials.
23
 The functional 
groups hydrogen bond to form this carboxylic acid dimer, i.e. a synthon. 
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1.5 Intermolecular interactions 
As was previously stated, intermolecular interactions are essentially the cement holding 
the crystal structure together. These interactions are specifically defined as being between 
atoms that are not directly bonded.
25
 Intermolecular interactions are classified according to 
their strength with respect to distance and their directionality.
25
 Medium-range forces 
generally govern close-packing, and include interactions such as C···H, C···C and H···H 
interactions.
21
 Long-range forces include heteroatom interactions, namely interactions 
among N, O, S, Cl, Br, I or any of these atoms and carbon or hydrogen.
21, 25
 These 
interactions generally lead to a minimisation of the free energy of the crystal lattice.
26
 
There is a wide variety of possible intermolecular interactions, but only the interactions 
pertinent to this study will be briefly discussed. 
1.5.1 The hydrogen bond 
The hydrogen bond is possibly the most well-known intermolecular interaction in crystal 
engineering and has been called the „master-key of molecular recognition‟.14 In its 
simplest form, it can be written as X-H···A with X being the donor and A the acceptor.
27
 
It is such a well-known interaction due to the fact that it is relatively strong and suitably 
directional.
27
 If a molecule contains a functional group that has the ability to form a 
hydrogen bond, it will always do so, unless there are factors such as steric hindrance that 
prohibit this from happening.
27
  
These bonds can be classified as very strong, strong and weak.
28
 This depends on how 
successfully the hydrogen bond in question can direct the aggregation of the molecules in 
any crystal structures obtained.
27
 The strength of the hydrogen bond is also dependent on 
the atoms that are involved in the hydrogen bond.
29
 For neutral molecules the typical 
values for a hydrogen bond are in the range of 10 – 65 kJ mol-1. If one of the species that 
is taking part in the hydrogen bond is ionic (a charge assisted hydrogen bond) the strength 
of the interaction can increase to 80 – 120 kJ mol-1.29 Weak hydrogen bonds involve 
interactions between O-H···Ph and CC-H···O that are barely stronger than van der 
Waals interactions.
27
 These weaker bonds can however still play an important role in 
directing the aggregation of molecules in the solid state.
28, 29
 To guide the crystal engineer 
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in designing molecular solids with the aid of hydrogen bonding, Etter and co-workers 
developed the following guidelines
28
: 
(i) All good proton donors and acceptors are used in hydrogen bonding. 
(ii) The formation of six-membered ring intramolecular hydrogen bonds will take 
preference over the formation of intermolecular hydrogen bonds. 
(iii) After the formation of intramolecular hydrogen bonds, the remaining best 
proton donors and acceptors will form hydrogen bonds. 
The hydrogen bond is clearly a well-researched and robust interaction that is often used in 
crystal engineering to direct supramolecular assemblies. 
1.5.2 π-π Stacking interactions 
This type of interaction occurs between aromatic rings and ranges in the value of 0 – 50 kJ 
mol
-1
.
12
 These stacking interactions can be divided into two types: face-to-face and edge-
to-face.
12
 It has been shown that this stacking interaction is due to the interaction between 
a positive σ-framework of one molecule and the negatively charged π-cloud of the other 
molecule.
30
 It has been suggested that nondirectional van der Waals stabilisation also 
plays an important role in stabilising these interactions.
31
  
 
 
 
 
 
1.5.3 Halogen bonding 
This term describes the attractive donor-acceptor interactions of halogen atoms that play 
the role of a Lewis acid.
32
 The halogens can either interact with other halogen atoms, or 
with carbon or nitrogen atoms. The angle of the intermolecular halogen bond can be found 
in the range 160° to 180°, even for weak interactions where the interaction distance is 
Figure 1.5 The two types of π-π stacking 
interactions.
21 
Stellenbosch University http://scholar.sun.ac.za
C h a p t e r  o n e  -  I n t r o d u c t i o n  
 
9 | 1  
 
greater than 3 Å.
32
 Figure 1.6 illustrates some of the elements normally involved in 
halogen bonding. 
 
 
 
 
 
 
 
 
 
1.5.4 Van der Waals forces and close packing 
Van der Waals interactions occur because of the polarization of the electron cloud of a 
molecule by the close proximity of a nearby nucleus. This results in weak electrostatic 
interactions.
12
 The value for this type of interaction is variable, but generally less than 5 
kJ/mol. These types of interactions include the induced dipole to induced dipole, or 
London forces.
14
 Van der Waals interactions provide a general attractive interaction for 
assembly of molecules in the solid state, but they are unfortunately not strongly directing 
interactions.
12, 33
 The interplay between attractive and repulsive forces allows molecules to 
orientate themselves in such a way as to utilise all available space and pack efficiently.
14
  
1.6 Co-crystals 
There has been much debate about how to define this seemingly innocent term.
34
 Dunitz 
described the co- in co-crystal as indicating “togetherness”,35 i.e. two or more components 
crystallising together in the same crystal structure. 
N X
X = I, Br 
N X
X = I 
CN I
X X
X = I, Br, Cl 
X = I, Br, Cl 
N X
Figure 1.6 Some of the halogen-based supramolecular synthons used in crystal engineering. 
Adapted from Metrangelo and Resnati in Encyclopedia of supramolecular chemistry
32 
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For the purpose of this study, the term „co-crystal‟ will be defined as a multicomponent 
molecular crystal as described by Bond.
36
 Furthermore, some of the restrictions placed on 
the term by Aakeröy and Salmon
37
 will also be used in this study. Only multicomponent 
crystals that contain neutral chemical species will be accepted as co-crystals and the 
different chemical entities comprising the crystal have to be present in stoichiometric 
amounts.
37
 Aakeröy and Salmon placed a further restriction on co-crystals, stipulating that 
the components of the co-crystal have to be solids at ambient conditions. This restriction 
therefore excludes solvates as co-crystals. In this study solvates will be considered as a 
subclass of co-crystals, meaning the components of the co-crystal do not have to 
specifically be solids at ambient conditions.  
It is unfortunately not a trivial exercise to prepare co-crystals. It appears to be 
thermodynamically more favourable for similar molecules to assemble in a solid, rather 
than heteromeric molecules.
17
 The interactions between the heteromeric molecules must 
therefore be much more favourable than the interactions between homomeric molecules 
for co-crystallisation to occur. In order to design co-crystals an understanding of the 
intermolecular interactions between functional groups is essential. This understanding will 
guide the choice of co-crystal formers used in co-crystallisation experiments.
38
 
1.7 Crystal engineering in cyclotriphosphazenes 
1.7.1 Inclusion studies with tris(o-phenylenedioxy)cyclotriphosphazene (TPP) 
It is nearly impossible to study cyclotriphosphazenes without being guided to studies done 
with TPP (Figure 1.7).
39
 TPP is made by the reaction between catechol and phosphonitrilic 
chloride trimer in the presence of a base. The product of this reaction (once crystallised) is 
a highly robust inclusion complex that includes a variety of solvents, whether it is exposed 
to the solvent or only the vapour. 
40-42
 The high density, nonporous structure of TPP 
(Figure 1.7) has also been characterised and it has been shown that under CO2 pressure the 
high density structure can be transformed to the low density, porous structure.
43
 Not only 
does this particular organic host include a wide variety of small organic molecules, but it 
has also been shown to include various polymers.
44, 45
 The sorption properties of TPP are 
however not what prompted this study. It was speculated that if TPP has the ability to 
form a broad range of inclusion compounds, the possibility exists that other 
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cyclotriphosphazene derivatives could also form a range of interesting supramolecular 
assemblies – be they inclusion compounds or co-crystals.  
 
 
 
 
 
 
 
1.7.2 Hydrogen bonded supramolecular networks of cyclotriphosphazene 
hydrazides 
The specific design of organic molecules into assemblies that are guided by hydrogen 
bonding has been extensively studied.
21, 23
 Benzene serves as the basis to which a wide 
range of modifications can be made in order to create the potential for hydrogen bonding 
interactions to guide the assembly of the organic molecules in the solid state. In the area of 
inorganic chemistry the molecules with the closest resemblance to benzene are the 
cyclotriphosphazenes. Chandrasekhar and co-workers
46
 used cyclotriphosphazenes and the 
principles of directional hydrogen bonding to design supramolecular assemblies in the 
solid state. They specifically selected hydrazide derivatives with the intent of using the 
terminal –NH2 groups as proton donors and the ring nitrogen atoms as proton acceptors. 
This interaction results in the formation of a hexagonal close-packed sheet in the case of 
N3P3[N(Me)NH2]6 (Figure 1.8a). When one of the phosphorus atoms is substituted with a 
2,2-biphenol group - spiro-N3P3[O2C12H8][N(Me)NH2]4 - it results in the formation of a 
double chain through hydrogen bonding of a ring nitrogen atom to a N(Me)NH2 
substituent (Figure 1.8b). This is one of the few examples of using tailored intermolecular 
interactions to direct the aggregation of cyclotriphosphazenes. 
Figure 1.7 A packing diagram of TPP showing the high density structure with no channels (left) and the 
low density, porous phase (right). 
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1.7.3 Co-crystals with cyclotriphosphazenes 
There are a number of known co-crystals containing a 
cyclotriphosphazene derivative.
47-49
 One of the most interesting co-
crystals is that of hexakis(4-carboxyphenoxy)cyclotriphosphazene 
and hexakis(4-pyridylcarbinoxy)cyclotriphosphazene (Figure 1.9).
50
 
Hydrogen bonds are formed between the carboxylic acid and pyridyl 
groups on the cyclotriphosphazenes. Due to the three-up and three-
down arrangement of the substituents on each cyclotriphosphazene, 
they assemble to form columns in the crystal structure. There are 
however no 3D-coordinates for this structure in the Cambridge 
structural database. It was decided to attempt to grow crystals of this 
particular co-crystal to be able to study the interactions in the 
structure. This co-crystal therefore served as the inspiration to design 
similar pillared assemblies with other cyclotriphosphazene 
derivatives. 
Figure 1.9 The 
pillared assembly 
of the carboxylic 
acid and pyridyl 
cyclotriphosphaze
ne derivatives. 
Figure 1.8 (a) The hexagonal close-packed sheets of N3P3[N(Me)NH2]6. (b) The double chains of 
spiro-N3P3[O2C12H8][N(Me)NH2]4 where a N(Me)NH2 substituent hydrogen bonds to a ring 
nitrogen. 
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1.8 This study 
True to the field of supramolecular chemistry, this project is a multi-disciplinary approach 
to design supramolecular assemblies of cyclotriphosphazenes. This research was not 
pursued for its potential practical applications, but rather for the contribution to the 
fundamental knowledge of crystal engineering. The more we understand, the better we can 
apply our knowledge with the eventual goal of real-life, practical applications. 
This study aimed to synthesise various known cyclotriphosphazene derivatives, using 
synthetic skills from both organic and inorganic chemistry. The aim was to synthesise 
cyclotriphosphazene derivatives with functional groups that have the potential to form 
strong supramolecular synthons with suitable small molecules in the solid state, i.e. to 
form co-crystals of cyclotriphosphazenes. Intensive research has been conducted into the 
synthesis of cyclotriphosphazenes, but few studies have been done on the potential to form 
co-crystals with cyclotriphosphazenes. An initial survey of the Cambridge Structural 
Database (CSD) also indicated that there are very few known co-crystals with 
cyclotriphosphazenes, therefore this study aimed to fill this apparent gap in the literature 
regarding the supramolecular chemistry of cyclotriphosphazenes.  
This study used various crystal growth techniques to investigate the occurrence of co-
crystal formation with cyclotriphosphazenes. This investigation will aid in the 
understanding of intermolecular interactions and which factors play a role in the assembly 
of these molecules in crystals. The results from this study will help to determine whether 
the intermolecular interactions controlling the assembly of cyclotriphosphazenes in the 
solid state are a reliable and robust way of designing supramolecular architectures with 
predictable packing arrangements. 
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Synthet ic  methods  
Cyclotriphosphazenes were chosen as the building blocks for this study because of the 
relative ease with which the chloro substituents can be replaced. The synthesis of a great 
variety of cyclotriphosphazene derivatives has been reported,
1-4
 but only the 
cyclotriphosphazenes that contained functional groups with either the potential for 
hydrogen or halogen bonding were selected for this study. The synthetic procedures that 
proved to be more challenging than initially expected will be discussed in this chapter, as 
well as the alternative and novel methods that were developed. Because the aim of this 
study was to generate co-crystals, any syntheses that did not yield immediate positive 
results were abandoned without making attempts to characterise by-products or optimise 
reaction conditions. The detailed experimental procedures for all successfully synthesised 
cyclotriphosphazene derivatives are listed at the end of this chapter.  
All reactions were carried out under dry nitrogen using standard inert atmosphere 
techniques, in this case Schlenk techniques, unless otherwise stated. 
2.1 General procedure for the synthesis of a cyclotriphosphazene derivative 
The procedure for preparing most cyclotriphosphazene derivatives is essentially the same: 
the desired substituent is deprotonated by a suitable base and allowed to react with the 
phosphonitrilic chloride trimer under reflux conditions. The work-up differs depending on 
the solubility and air sensitive nature of the product. The reactions are normally carried 
out in THF, acetone or DCM with reflux. These are however not the only solvents that are 
used, but this largely depends on the reactivity of the reagents. If more energy is required 
to activate the reaction, then a solvent with a higher boiling point should be used.  
For the reaction to take place, the desired substituent (normally a phenol derivative) needs 
to be deprotonated. This is done by adding a base such as potassium carbonate (K2CO3) or 
triethylamine. The base has to be added either in slight excess or in an amount equivalent 
to the substituent. In the case of triethylamine, two equivalents of base have to be added: 
one equivalent to deprotonate the reagent and another equivalent to trap the HCl that is 
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formed during the reaction.
5
 The reaction mixture is then refluxed for two to twelve hours, 
depending on the reactivity of the reagents. The work-up involves removing the solvent in 
vacuo, either before or after filtering, and washing the residue with an appropriate solvent, 
which in some cases is water. A variety of solvents can be used for recrystallisation and 
purification of the crude product. 
Scheme 2.1 lists all the derivatives that were synthesised (or attempted) during this 
project. Each derivative has been numbered for ease of reference. The syntheses of 1 – 6 
will be described in detail. The syntheses for 7 – 16 can be found at the end of this chapter 
in section 2.7. 
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Scheme 2.1 A list of all the cyclotriphosphazene derivatives that were synthesised (or attempted, in the case of 
1) in this study. 
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2.2 Attempted synthesis of 2,2-bis(4-formylphenoxy oxime)- 4,4,6,6-
bis[spiro(2,2-dioxy-1,1-biphenylyl]cyclotriphosphazene (1)6 
Various attempts were made at synthesising the oxime derivative of the 
cyclotriphosphazene depicted in Scheme 2.1. The reason why this specific molecule was 
chosen for synthesis is because of the oxime group, which has a high propensity to form 
hydrogen bonds in the solid state.
7-9
 The motive behind incorporating bulky biphenyl 
groups in the molecule is the hope that these groups would prohibit the molecule from 
packing efficiently in the solid state, therefore allowing voids to form that could 
potentially be filled with solvent. 
The synthesis of 1 is a three-step process where the bulky groups are first attached to the 
cyclotriphosphazene ring. This product (2) is allowed to react with 4-
hydroxybenzaldehyde and then lastly the aldehyde is converted to the oxime. The last step 
proved to be more problematic than anticipated, and various methods were used to attempt 
to convert the aldehyde to the oxime. 
The first step in the synthesis of 1 is to produce the dioxybiphenyl derivative 2 via the 
reaction depicted in Scheme 2.2. Two equivalents of biphenyl-2,2-diol were added to four 
equivalents of potassium carbonate. In this case only two equivalents of the reagent are 
needed as one biphenyl-2,2-diol is capable of bonding to one phosphorus atom through 
the two deprotonated oxygen molecules. Two phosphorus atoms are then substituted with 
this bulky group. 
 
 
 
 
This reaction was performed in acetone as the reaction has been proven to occur faster in 
acetone than in THF.
10
 It was also not necessary to reflux the first step in this reaction as 
this bifunctional nucleophile promotes the replacement of the chlorine atoms. In fact, the 
trimer and biphenol were added to acetone that was cooled in an ice bath. This is 
N
P
N
P
N
P
Cl Cl
Cl
ClCl
Cl
OH HO
K2CO3
acetone P
N
P
N
P
N
O
O O
O
ClCl
Scheme 2.2 First step in the synthesis of 1. 
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presumably done to prevent the reaction from taking place too fast and forming trimer that 
is triply substituted with biphenyl-2,2-diol.10 When the first nucleophilic oxygen reacts 
with the phosphorus atom, it activates the phosphorus atom for further substitution 
(geminal substitution).
11
 The neighbouring oxygen is the next-closest nucleophile and 
substitution of the second chlorine atom occurs. Crosslinking of trimer molecules does not 
occur because the closest reactive site is on the same molecule.
10
 The reaction mixture was 
stirred at room temperature for 24 hours under an atmosphere of dry nitrogen because the 
biphenyl-2,2-diol is air sensitive. The solvent was then removed under vacuum and the 
product extracted with DCM. More than one product can potentially form during the 
reaction, but the main product is isolated via extraction and recrystallisation as the 
solubility of the doubly and triply substituted derivatives differs in different solvents. 
Characterisation was done by 
1
H and 
31
P NMR spectroscopy. The 
1
H NMR spectrum 
indicated the presence of the protons of the biphenyl-2,2-diol and 31P NMR showed two 
signals, a doublet and doublet of doublets (dd) that overlap (Figure 2.1). The doublet can 
be assigned to the phosphorus atoms that have been substituted with the biphenyl-2,2-diol 
due to coupling to the phosphorus atom with the chloro groups. This will give the 
phosphorus atoms a multiplicity of two (multiplicity = n+1).
12
 The dd is therefore the 
phosphorus atom with the chlorine atoms as substituents, which couples to the other two 
phosphorus atoms that are not exactly chemically equivalent. The coupling is however 
close enough to cause the doublets to overlap to some extent. The peak at 26.34 ppm is 
due to the presence of a small amount of the triply substituted derivative. 
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The reaction depicted in Scheme 2.3 was carried out by refluxing in THF for eight hours 
to produce 3.
6
 It is necessary to reflux in this step as the groups on the 
cyclotriphosphazene ring are quite bulky, causing steric hindrance which would mean that 
the reaction will need more energy to take place. It was not necessary to do this reaction 
under inert conditions. The work-up for the second step is similar to the first step. The 
solvent was removed under vacuum and the product extracted with DCM. The DCM was 
then removed in vacuo. 
1
H and 
31
P NMR spectroscopy confirmed the synthesis of the 
aldehyde. 
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O
O
O
O
O
O
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Scheme 2.3 Step two in the synthetic procedure for the biphenyl aldehyde derivative. 
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Figure 2.1 
31
P NMR of 2. The phosphorus atom substituted with the chloro groups is the overlapping 
doublet of doublets at 29.87 ppm. The doublet at 19.79 ppm is the two phosphorus atoms substituted 
with the biphenyl-2,2-diol. 
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The oxime can be produced by condensation of the aldehyde with hydroxylamine 
hydrochloride in the presence of a polar, aprotic solvent such as pyridine.
6
 This mixture 
was allowed to reflux for 3.5 to 4 hours and on cooling, poured slowly into water. This 
resulted in the formation of a dark, gel-like substance that could not be filtered off. 
Repeated attempts to precipitate the product from water did not yield any positive results. 
Efforts were made to dissolve the gel-like substance in an organic solvent, effectively 
extracting the product. A saturated sodium chloride solution was then added to the organic 
layer in order to induce the precipitation of 1. This was unfortunately also unsuccessful. 
The synthesis was reattempted, but alternative methods were tried to convert the aldehyde 
to the oxime, as pyridine is a highly unpleasant and toxic substance to handle. 
2.2.1 Attempted oxime synthesis via sonication13, 14 
According to an article by Li and co-workers in Ultrasonics Sonochemistry,
13
 it is possible 
to convert an aldehyde to an oxime by a condensation reaction of the aldehyde with 
hydroxylamine hydrochloride in ethanol with sonication. However, 3 is not soluble in 
ethanol, therefore THF was used. Two equivalents of hydroxylamine hydrochloride and a 
small amount of sodium sulfate were added and the reaction mixture was sonicated for 30 
minutes. The mixture was then filtrated and the solvent was removed under reduced 
pressure. The residue was dissolved in DCM and washed with water. The organic layer 
was then dried on anhydrous magnesium sulfate, filtered and the solvent removed. 
Unfortunately the small amount of product that was isolated was shown to be starting 
material, as analysed by thin layer chromatography (TLC), 
1
H and 
31
P NMR. Sonication 
time was varied from 10 minutes to an hour, although this was also not successful. 
N
P
N P
N
P
O
O
O
O
O
O
N
N
HO
HON
P
N
P
N
P
O
O
O
O
O
O
O
O
hydroxylamine hydrochloride
pyridine
Scheme 2.4 This synthetic step involves the conversion of the aldehyde to the oxime by a condensation 
reaction of 3 with hydroxylamine hydrochloride. 
Stellenbosch University http://scholar.sun.ac.za
C h a p t e r  2  –  S y n t h e t i c  m e t h o d s  
 
8 | 2  
 
2.2.2 Attempted mechanochemical conversion of an aldehyde to an oxime7 
Mechanochemical synthesis involves the grinding together of two compounds in the solid 
state, either with or without solvent. Grinding for a certain amount of time can supply the 
energy needed for a reaction to take place.
7, 15
 
Two equivalents of sodium hydroxide and hydroxylamine hydrochloride were ground 
together with derivative 3 while adding four to five drops of a 1:1 mixture of DCM and 
ethanol. The mixture was ground for approximately five minutes until the sample was dry. 
This mixture was then washed with water to remove any excess sodium hydroxide and 
inorganic salts formed during the reaction and dried in air. 
1
H NMR analysis unfortunately 
indicated that no reaction had taken place (Figure 2.2). In the case of successful 
conversion, the signal for the aldehyde proton at 10.03 ppm would no longer be observed. 
The signal for the proton on that carbon would have shifted further downfield if the 
aldehyde was converted to the oxime. There would also have been two signals 
representing the different isomers of the oxime.
6
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Figure 2.2 
1
H NMR results for the attempted conversion of 3 to 1. The signal at 10.02 ppm 
unfortunately corresponds to the signal for the aldehyde proton. The insert is taken from the 
1
H 
spectrum of 3. 
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2.2.3 The crystal structure of 3 
As we were not able to synthesise the oxime derivative 1, it was decided to conduct co-
crystallisation experiments with 3 to attempt to form co-crystals. These experiments will 
be described in greater detail in Chapter 4. Even though the aldehyde moiety is not a very 
strong hydrogen bond acceptor, co-crystallisation experiments were carried out with 
hydrogen bond donor molecules such as acids, alcohols and amines. A crystal of 3 was 
isolated from a co-crystallisation experiment with 1,6-dihydroxynaphthalene in THF. Data 
was collected at 100 K and the structure of this derivative was determined (Figure 2.3). 
The biphenyl-2,2-diol substituents on the cyclotriphosphazene ring were expected to 
disrupt efficient packing of the molecule and subsequently create voids in the solid state 
structure. This is however not the case as the molecule still packs efficiently, leaving no 
cavities (Figure 2.4). It packs in the monoclinic crystal system in the space group P21/n. 
 
 
 
Figure 2.3 A capped stick representation of 3. (a) This image illustrates the conformation of the 
biphenyl-2,2’-diol substituents. (b) One of the benzaldehyde substituents is disordered over two 
positions (pink and green). Hydrogens have been omitted for clarity. 
a) b) 
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One of the benzaldehyde groups is disordered over two positions, shown in green (53%) 
and pink (47%) in Figure 2.3b. Occupancy is therefore nearly equal for the two positions. 
There are no hydrogen bonds evident in the structure, confirming that the aldehyde moiety 
is not a strong hydrogen bond acceptor. The molecules form discrete dimers via an offset 
face-to-face interaction between benzaldehyde groups (Figure 2.4a). These dimers form 
chains through π-stacking interactions of the biphenyl groups (Figure 2.4b). The chains 
then close-pack with close contacts between the biphenyl groups (Figure 2.4c). 
Figure 2.4 Packing in 3. (a)The benzaldehyde moieties 
form discrete dimers via an offset face-to-face 
interaction. To aid the eye, it can be viewed as though 
the dimers form chains as seen in (b), indicated by the 
blue dotted lines. This is viewed down the 
crystallographic a-axis. The chains then close-pack as 
seen in (c) with close contacts between the biphenyl-
2,2’-diol groups. 
a) 
b) 
c) 
b 
c 
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2.3 Synthesis of the hexakis(4-pyridyloxy)cyclotriphosphazene (4) 
The pyridyloxy cyclotriphosphazene derivative has previously been synthesised and 
characterised by single crystal X-ray diffraction analysis.
16
 It has been shown that this 
compound undergoes coordination to transition metals.
16, 17
 
 
 
The first synthetic procedure that was followed was the one set out by Carriedo and co-
workers.
16
 The phosphonitrilic chloride trimer, six equivalents of 4-hydroxypyridine and 
six equivalents of potassium carbonate were refluxed in acetone for five hours under strict 
inert conditions. The solvent was removed under vacuum and the residue extracted with 
acetone. While extracting the residue by cannula filtration, dark green and black particles 
appeared in the solution. This is possible evidence that the product or reagents had begun 
to degrade due to contact with moisture. This solution was then stirred with ammonium 
chloride for 30 minutes, after which the solvent was evaporated and the residue extracted 
with toluene. The final product, after removal of toluene under vacuum, was recrystallised 
from DCM/petroleum ether. The yield for this reaction was very low (only 8 %) and no 
suitable crystals could be grown from the solvent system. It was not possible to do any 
analysis or carry out any co-crystallisation experiments with such a small amount of 
product. It was decided to search for better synthetic methods or modify 4 to make it more 
stable. 
Figure 2.5 Capped stick representation of the 
structure of the hexakis(4-pyridyloxy)-
cyclotriphosphazene (4). 
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The modification of 4 was first attempted by trying to incorporate one biphenyl-2,2-diol 
group into the structure 
17, 18
 This was done by refluxing in THF as was previously 
described in this chapter, but only one equivalent of biphenyl-2,2-diol was added. The 
second part of the procedure was again carried out in refluxing acetone under inert 
conditions.
17
 The first attempt yielded a yellow solution, whereas the second attempt 
yielded a red solution, and on removal of the solvent, a dark red solid. 
1
H and 
31
P NMR 
analysis of the dark red solid did not give any conclusive evidence that it was the desired 
product. Attempts to recrystallise the product from various solvents were also not 
successful as crystals only appeared to be that of various starting materials. Other attempts 
were also made to synthesise 4, such as forming the sodium 4-pyridinoxide before 
reacting it with the phosphonitrilic chloride trimer, but they were also unsuccessful.
19, 20
 
 
A final attempt adapted from work done by Carriedo and co-workers
21
 was made where 
the reaction mixture containing phosphonitrilic trimer, 4-hydroxypyridine and potassium 
carbonate in THF was stirred for two and a half days at room temperature, after which the 
mixture was refluxed for approximately six hours (Scheme 2.5). The solvent was removed 
and the residue was dispersed in 100 ml water. The white precipitate was isolated by 
filtration and dried. NMR analysis (Figure 2.6) was performed on the crude product 
(before further purification) and very clean spectra were obtained, indicating successful 
synthesis of the pyridyloxy derivative. Simpler is evidently better! One novel co-crystal 
with 4 has been isolated and will be discussed in detail in chapter 4. 
N
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Cl Cl
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H2O
N
P N
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O
OO
O
N
N
N
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Scheme 2.5 The successful synthetic procedure for the hexakis(4-pyridyloxy)cyclotriphosphazene. The 
final product is precipitated from water. 
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Figure 2.6 The 
1
H (top) and 
31
P (bottom) analysis of the pyridyloxy derivative. Each of the signals at 8.50  
and 6.95 ppm integrate for two protons of one ring. There is only one signal in the 
31
P spectrum, indicating 
complete substitution of the cyclotriphosphazene ring as all of the phosphorus atoms are chemically 
equivalent. 
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2.4 Synthesis of a hexa(4-cyanophenyl)cyclotriphosphazene (5) 
Allcock
22, 23
 was one of the first to obtain a crystal structure of a cyclotriphosphazene 
containing the cyano functionality (Figure 2.7). These groups are quite sought after in 
supramolecular chemistry as they can coordinate to transition metals
23
 and halogens. For 
this reason it was decided to attempt to synthesise a cyano derivative.  
 
The compound in Figure 2.7a was isolated in very low yield in the literature (5 %).
23
 It did 
therefore not seem to be a feasible idea to synthesise a product in such low yield if a large 
number of crystallisation experiments needed to be conducted. A cyclotriphosphazene 
with the cyanophenyl functionality has also been reported in the literature, although not 
characterised by single crystal X-ray diffraction (SCD).
24
 The synthetic route is very 
simple and identical to the procedure followed for the pyridyloxy derivative described 
earlier and therefore it was decided to attempt the synthesis of this molecule (Scheme 2.6). 
It was surmised that the cyanophenyl groups would allow the molecules to pack in 
columns in the crystal structure, or allow for halogen-nitrile interaction.  
Figure 2.7 Cyclotriphosphazenes containing cyano substituents are shown in this figure.
23
 These 
compounds are stable in air and do not decompose when heated to moderate temperatures. The molecule 
in (b) has two cyano groups that point in the same direction, while the other points in the opposite 
direction. 
a) b) 
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In this case the reaction mixture was not stirred at room temperature for two to three days 
because the cyano group is a highly electron-withdrawing group that activates the 
phosphorus atom for substitution.
24
 The phosphonitrilic chloride trimer, 4-cyanophenol 
and potassium carbonate were refluxed for six hours in THF and after completion of the 
reaction the solvent was removed under vacuum. The residue was washed with water and 
the product isolated by filtration. 
1
H and 
31
P analysis revealed that the white product was 
pure (Figure 2.8) and that substitution of the chlorine atoms of the phosphonitrilic chloride 
trimer had occurred completely because a singlet was present in the 
31
P spectrum (Figure 
2.9). 
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Scheme 2.6 The synthetic procedure for the cyanophenyl derivative. The procedure is identical to that of the 
pyridyloxy derivative. 
Figure 2.8 The 
1
H analysis of the cyanophenyl derivative. The two signals in the 
1
H spectrum 
correspond with the aromatic protons of the cyanophenyl group.  
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Solid state infrared analysis also confirmed the presence of the nitrile functionality (Figure 
2.10). The peak at 2225 cm
-1
 is caused by the CN stretch. 
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Figure 2.9 
31
P analysis of the cyanophenyl derivative. The 
31
P spectrum shows only one signal, 
indicating that complete substitution occurred as all phosphorus atoms are chemically equivalent. 
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Figure 2.10 The infrared spectrum of hexakis(4-cyanophenoxy)cyclotriphosphazene. The peak at 
2225.95 cm
-1
 is due to the CN stretch. 
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The product is sparingly soluble in most solvents, except for DMSO and DMF in which it 
readily dissolves. Rod-shaped crystals of 5 were grown from a co-crystallisation 
experiment with bromopentafluorobenzene in DMSO. Data was collected at 100 K and the 
structure was determined (Figure 2.11). Two cyanophenyl rings are twisted towards each 
other, forming pairs in the molecule above and below the plane of the cyclotriphosphazene 
ring. One cyanophenyl ring forms a short contact with a molecule beneath it in the chain, 
allowing for propagation of the chain (Figure 2.12). 
 
The remaining cyanophenyl ring faces away from the molecule, allowing for interaction 
between the chains. The chains interact via offset face-to-face π-interactions, shown in red 
in Figure 2.12a as well as edge-to-face π-interactions shown in green in Figure 2.12b. 
 
 
 
 
 
 
 
Figure 2.11 This figure illustrates the conformation of the cyanophenyl 
rings. Two of these rings are twisted towards each other, one pair on each 
side of the phosphorus-nitrogen ring.  
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2.5 Attempted synthesis of a cyclotriphosphazene with carboxylic acid 
functionality 
The carboxylic acid group is a functional group that readily forms hydrogen bonds – a 
feature that is essential in crystal engineering. The crystal structure of the carboxylic acid 
derivative seen in Scheme 2.7 has also not yet been elucidated, therefore various attempts 
were made to synthesise this derivative. The first method used involved the hydrolysis of 
an ester in basic medium
25
 (Scheme 2.7). 
Figure 2.12 (a) Close contacts between the nitrile groups and hydrogens allow the molecules to form a 
chain. (b) These chains close pack via edge-to-face (green dotted lines) and offset face-to-face π-
interactions (red dotted lines). 
a) 
b) 
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Scheme 2.7 The first method used in the attempt to synthesise the carboxylic acid derivative. This 
involves the basic hydrolysis of an ester to yield the carboxylic acid. 
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A mixture of phosphonitrilic chloride, ethyl-4-hydroxybenzoate and triethylamine was 
stirred in dry toluene at room temperature for 25 hours.
26
 Triethylamine serves as the base 
that deprotonates the ethyl-4-hydroxybenzoate. Smaller bases like sodium hydride or 
sodium hydroxide were not used for the first step because they can react with the ester at 
the carbonyl carbon, rather than deprotonating only the hydroxyl group.
25
 This then leads 
to the premature formation of the acid. It is also possible that if the ester is first hydrolysed 
to the carboxylic acid and is then allowed to react with the phosphonitrilic chloride trimer, 
coordination to the phosphorus atom can occur through one of the carboxylate oxygen 
ions, rather than the hydroxyl oxygen. The amine hydrochloride was filtered off and a 
large proportion of the solvent was removed, although the product could not be purified or 
dried. 
31
P NMR analysis indicated that a variety of phosphorus-containing by-products 
had formed during the reaction (Figure 2.13). This could either imply that the 
phosphonitrilic ring system had opened up and polymerised,
27
 or that products of various 
degrees of substitution had formed. The product was used as is for the rest of the synthetic 
procedure. It was dissolved in aqueous methanol and hydrolysed with sodium hydroxide.
28
 
This mixture was then poured into an excess of water and acidified with 2 M hydrochloric 
acid. A small amount of white solid was collected and washed with water. NMR analysis 
was performed on the sample (Figure 2.14) and the 
1
H spectra showed that the ester had 
not been hydrolysed. If it had been hydrolysed, the signal for the ethyl group would no 
longer be visible. This is however not the case as the signals for the methylene and methyl 
protons are still visible in the spectrum, integrating for two and three protons respectively. 
There is even a weak signal present for the proton of the hydroxyl group, indicating that 
substitution had also not taken place. The 
31
P spectrum only shows one weak signal at a 
chemical shift too far downfield for the expected product.
27, 29
 This NMR spectrum also 
corresponds with the NMR spectrum of the starting material, ethyl-4-hydroxybenzoate. 
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Figure 2.13 This 
31
P spectrum shows that many phosphorus-containing side-products formed during the 
reaction.  This could however also indicate the polymerisation of the cyclotriphosphazene. 
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Figure 2.14 
1
H analysis shows the presence of ethyl-4-hydroxybenzoate and not the carboxylic acid. 
The signals for the methylene and methyl protons are still present, integrating for two and three 
protons respectively. The peak at 10.30 ppm is that of the hydroxyl group, indicating that substitution 
onto the cyclotriphosphazene ring did not occur. 
O
OH
O
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The second method that was used to try to synthesise the carboxylic acid was the 
oxidation of an aldehyde to a carboxylic acid, illustrated in (Scheme 2.8).
30-32
 
 
The first step seen in Scheme 2.8 involves the substitution of the chlorine atoms on the 
cyclotriphosphazene ring by 4-hydroxybenzaldehyde. The potassium carbonate again acts 
as a base to deprotonate the hydroxyl group of the 4-hydroxybenzaldehyde. The reagents 
were dissolved in acetone as it has been shown that the combination of potassium 
carbonate and acetone allow the reaction to occur faster. This is due to the high polarity of 
the acetone which promotes a higher reaction rate.
24, 33
 The reaction mixture was refluxed 
for twelve hours and the solution filtered, yielding a yellow product. 
31
P NMR analysis of 
the yellow product indicated that all the phosphorus atoms had been fully substituted, with 
a single peak at 9.68 ppm. The chemical shift value reported in the literature is at 6.90 
ppm.
30
 The shift in the signal could be due to the different solvents used for NMR analysis 
– the analysis by Ye and co-workers was done in CDCl3 or benzene, whereas the NMR 
analysis in this study was done in DMSO. 
For the second step, tetrabutylammonium permanganate was needed. This was prepared 
by mixing aqueous solutions of KMnO4 and tetrabutylammonium bromide (N-n-Bu4Br) 
and collecting the purple precipitate.
32
 This is a potentially explosive substance, therefore 
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Scheme 2.8 The synthetic procedure for oxidising the fully substituted benzaldehyde to a 
cyclotriphosphazene containing the carboxylic acid functionality. 
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care must be taken to store it at a low temperature to slow down decomposition.
32
 
Tetrabutylammonium permanganate was added over a period of five hours to the 
hexakis(4-formylphenoxy)cyclotriphosphazene in pyridine. The reaction mixture was 
stirred for another hour and subsequently cooled in an ice bath. 5 % HCl and Na2S2O5 was 
used to quench the reaction and remove MnO2. The next step was to separate the acid by 
filtration, however no precipitate formed during this reaction. Extended cooling in the ice 
bath also did not yield any product. Attempts to extract any product from the reaction 
mixture were unsuccessful and analysis of the reaction mixture did not lead to any 
conclusive results; therefore it was decided to search for an alternative, preferably 
pyridine-free, synthetic route.  
First, substituting the chlorine atoms with p-aminobenzoic acid (PABA) was considered. 
This involved preparing a mixture of phosphonitrilic chloride trimer, PABA and 
triethylamine and refluxing for 24 hours in THF. The precipitate, aminehydrochloride, 
was filtered off and the filtrate acidified. The solvent was removed and the product was 
analysed by 
1
H and 
31
P NMR (Figure 2.15). From the 
31
P spectrum it is apparent that full 
substitution had not occurred, because rather than the expected singlet of a fully 
substituted ring, various doublets and triplets were observed. 
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Figure 2.15 The 
31
P spectrum of the product of the reaction between phosphonitrilic chloride trimer and 
PABA. Peaks are observed much further upfield than is usual for substituents with a nitrogen linker. 
Stellenbosch University http://scholar.sun.ac.za
C h a p t e r  2  –  S y n t h e t i c  m e t h o d s  
 
23 | 2  
 
Attempts were made to change the reaction conditions. These included changing the 
solvent to a higher boiling solvent like acetonitrile and refluxing for longer periods of 
time. However, these reactions were still not successful. It was decided to try 
mechanochemical synthesis in an attempt to provide the reagents with the necessary 
energy for the reaction to take place. This involves grinding the different components 
together for 5, 10 or 30 minutes, with or without base. No solvent was used during these 
grinding experiments. Powder X-ray diffraction data was collected on each of the grinding 
experiments and the results compared. The results are shown in Figure 2.16. The 
diffractograms show that the products from the grinding experiments without any base 
present only appear to be a mixture of the starting materials. If a new compound had 
formed, the patterns would not correspond with the simulated patterns of PABA and 
phosphonitrilic chloride trimer. 
Figure 2.17 shows the results from grinding PABA and phosphonitrilic chloride trimer 
together in the presence of base. Upon grinding with the base, the powder becomes a thick 
brown paste after only a few minutes of grinding. Grinding without the base produced 
only powder samples creamy in colour. It is evident from Figure 2.16 that the patterns of 
the reagents and the products do not match. NMR analysis (Figure 2.18) did not yield any 
conclusive results as 
31
P NMR indicated the presence of phosphorus, but not at the 
chemical shift expected for the phosphonitrilic chloride trimer. It is possible that the ring 
degraded to some extent due to a reaction with the base. This method of synthesis was 
therefore also not successful.  
The last attempt at synthesising the carboxylic acid derivative consisted of reacting the 
hexakis(4-bromophenyl)cyclotriphosphazene (4) with nBuLi (n-butyl lithium). Hexakis(4-
bromophenyl)cyclotriphosphazene was dissolved in THF and the solution cooled in a 
slurry of dry ice and acetone to -78 °C. nBuLi was added to this solution, warmed up to 
room temperature and allowed to stir for 10 minutes. Excess dry ice was added to this 
solution and then the solution was washed with water. This is done to precipitate the 
product, however, no precipitate formed even on evaporation of the water. This synthetic 
procedure was also not successful. 
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Figure 2.16 Powder X-ray diffraction results from the grinding experiments. The ratio of phosphonitrilic chloride trimer:PABA is indicated in each case. Peaks from the 
two simulated patterns appear in the product of the grinding experiments. This indicates that the product is simply a mixture of the two starting materials.  
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Figure 2.17 Powder X-ray diffraction results of the grinding experiments with triethylamine as base. The ratio of N3P3Cl6:PABA is indicated. Only the results from 5 
minutes of grinding are shown as grinding for longer periods of time became increasingly difficult with the formation of the paste. 
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2.6 Conclusions 
In this study, out of the sixteen target molecules, fifteen cyclotriphosphazene derivatives 
were successfully synthesised. Most of these derivatives were synthesised using standard 
Schlenk techniques in order to perform the reactions under inert conditions.  
Two novel crystal structures of the cyclotriphosphazene derivatives have been identified 
and characterised using single crystal X-ray diffraction. These are hexakis(4-
cyanophenyl)cyclotriphosphazene (5) and 2,2-bis(4-formylphenoxy)-4,4,6,6-bis[spiro-
(2,2-dioxy-1,1-biphenylyl]cyclotriphosphazene (3). The crystal structures of both have 
been described in this chapter.  
Some synthetic procedures proved to be more challenging than expected and a variety of 
methods were employed in order to make the desired cyclotriphosphazenes. In some 
cases, the alternative method was successful, e.g. hexakis(4-pyridyloxy)-
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Figure 2.18 
31
P NMR analysis of the grinding product between PABA and phosphonitrilic chloride trimer in 
the presence of base. The spectrum indicates the presence of phosphorus, but signals for the phosphonitrilic 
chloride trimer usually occur at 19 ppm. 
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cyclotriphosphazene. The original synthetic method that was used required working under 
strict inert conditions,
16
 whereas the alternative method precipitated the derivative from 
water.
21
 It is possible that impurities in the cannula filter used for the first synthesis might 
have caused the degradation of the starting materials. This could explain why, during the 
second attempt at the synthesis of 4, less strict inert conditions still led to the formation of 
the correct product.  
A variety of methods were used to attempt to synthesise the hexakis(4-
carboxyphenoxy)cyclotriphosphazene. The procedure of exchanging the bromo groups of 
14 for lithium, and then using dry ice to convert it to the carboxylic acid has never before 
been attempted on cyclotriphosphazenes. However, this particular procedure did not prove 
to be immediately successful. Future work could include optimising the conditions for this 
reaction, as it has been proven successful in many organic synthetic procedures. Excess 
nBuLi could be added to ensure the reaction occurs to completion. The reaction mixture 
could also be left to react for longer, as in this particular experiment it was only left to stir 
for approximately 5 minutes. It is strongly recommended that further studies be done into 
the synthesis of the hexakis(4-carboxyphenoxy)cyclotriphosphazene as the carboxylic acid 
moiety forms part of a robust synthon often used in crystal engineering for its structure-
directing potential. A possible synthetic route could involve the use of 1,4-biphenol or 6-
hydroxy-naphthalene-4-carboxylic acid as reagents. If the molecule is conformationally 
restricted, it would significantly decrease the ability of the molecule to coordinate to the 
phosphorus atom through both oxygen atoms.  
Although the results of the attempted mechanochemical synthesis of the p-aminobenzoic 
acid derivative were inconclusive, it is definitely worthwhile to further analyse the 
products formed during the reaction. It is recommended that triethylamine be replaced 
with potassium carbonate which can be easily removed by washing the product with 
water. It is also possible to obtain a powder pattern of potassium carbonate to compare to 
the powder pattern of the product in order to investigate whether a reaction had taken 
place. 
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2.7 Detailed synthetic procedures 
Detailed procedures and reagent quantities for all cyclotriphosphazenes prepared in this 
study can be found in this section. All chemicals were purchased from Sigma-Aldrich and 
used without further purification. THF, diethylether and toluene were distilled over 
sodium sand or wire with benzophenone as indicator, under an atmosphere of dry 
nitrogen. DCM and acetonitrile were distilled over dried calcium hydride under an 
atmosphere of dry nitrogen. Acetone and n-hexane were distilled over dried calcium 
chloride under nitrogen. 
1
H and 
31
P NMR spectra were obtained using a 300 MHz Varian VNMRS or a 400 MHz 
Varian Unity Inova. Chemical shift values are in ppm and were referenced to either 
chloroform-d or DMSO-d6. Data for 
1H spectra are reported as chemical shift (δ ppm) 
(integration, multiplicity, coupling constant (Hz)). H3PO4 was used as an external standard 
for 
31
P NMR. 
Melting points for 2, 8, 3, 6, 12, 13, 14, 15 and 5 were determined by differential scanning 
calorimetry using a TA Instruments Q100 system under a N2 gas purge, with a flow rate of 
50.0 ml/min and heating rate of 10 C/min. The samples (ranging from 1.5 to 3 mg) were 
placed in aluminium pans that were non-hermetically sealed with vented aluminium lids. 
Melting points for 10 and 4 were determined by a Stuart SMP3 melting point apparatus in 
K10 glass capillary tubes. 
All reactions were performed under an atmosphere of dry nitrogen unless otherwise stated. 
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2.7.1 Tris(1,3-diaminopropane)cyclotriphosphazene (7)34, 35  
N3P3Cl6 (0.5 g, 1.44 mmol) was dissolved in 50 ml of a 7:3 
mixture of n-hexane: DCM. 1,3-diaminopropane (0.8 ml, 8.64 
mmol) was added to this mixture,. The reaction mixture was 
refluxed for 4 hours after which the solution was cooled and 
filtered and the solvent removed under reduced pressure. The 
white powder was further purified by recrystallisation from 
methanol. Yield: 62% (0.313 g, 0.89 mmol). 
1
H NMR (DMSO-d6, 400 MHz): δ ppm 1.53 (2H, m), 3.04 (4H, m), 3.48 (2H, s), 
31
P NMR 
(DMSO-d6, 400 MHz, H3PO4): δ ppm 13.86 (d), 20.45 (t). 
Crystals of 7 were also grown from a THF/hexane solution. This proved to be the known 
hydrate.
34
 
2.7.2 2,2-Bis(4-formylphenoxy)-4,4,6,6-bis[spiro(2,2-dioxy-1,1-biphenylyl]-
cyclotriphosphazene
6
 (3) 
a. 2,2-Dichloro-4,4,6,6-bis[spiro(2,2-dioxy-1,1-biphenylyl]cyclotriphosphazene (2) 
N3P3Cl6 (2 g, 5.75 mmol), biphenyl-2,2-diol (2.14 g, 
11.51 mmol) and K2CO3 (3.98 g, 28.77 mmol) were 
mixed in 20 ml acetone at 0 °C. The reaction mixture 
was stirred at room temperature for 24 hours and when 
the reaction was complete the solvent was removed in 
vacuo. The product was extracted by washing with 15 
ml of DCM four times, filtering each time with a 
cannula filter. The solvent was then removed under vacuum to produce a white powder. 
Yield: 86 % (2.847 g, 4.96 mmol). Mp.: 268 – 275 C. 
1
H NMR (CDCl3, 300 MHz): δ ppm 7.55 (4H, d, J = 7.63 Hz), 7.46 (4H, d, J = 7.63 Hz), 
7.36 (8H, m), 
31
P NMR (CDCl3, 300 MHz, H3PO4): δ ppm 19.79 (d, C12O2H8), 29.19 (dd, 
Cl2). 
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b. 4,4,6,6-Tetrachloro-2,2-(biphenyl-2,2'-dioxy)cyclotriphosphazene (8)36 
A mixture of N3P3Cl6 (1.018 g, 2.88 mmol), 2,2-biphenol (0.543 g, 
2.88 mmol) and K2CO3 (2.013 g, 14.4 mmol) were stirred together 
in 40 ml acetone at room temperature for 30 minutes. The volatiles 
were evaporated in vacuo and the residue extracted with 4 x 15 ml 
DCM. The solvent was evaporated to give a white solid. The 
product was recrystallised from DCM/petroleum ether. Yield: 80% 
(1.071 g, 2.32 mmol). Mp.: 181 – 189 C. 
1
H NMR (CDCl3, 400 MHz): δ ppm 7.57 (2H, d, J = 7.62 Hz), 7.49 (2H, t, J = 7.42 Hz), 
7.41 (2H, t, J = 7.62 Hz), 7.33 (2H, d, 8.01 Hz), 
31
P NMR (CDCl3, 400 MHz, H3PO4): δ 
ppm 21.87 (d, Cl2), 9.74 (t, C12O2H8). 
c. Tris(2,2'-dioxybiphenyl)cyclotriphosphazene (17)10, 37 
N3P3Cl6 (1.003 g, 2.88 mmol), 2,2-biphenol (1.815 g, 
9.66 mmol) and K2CO3 (3.010 g, 21.8 mmol) were 
refluxed for 7 hours in 140 ml acetone. The solvent was 
evaporated in vacuo and the residue was washed with 
100 ml water, 100 ml aqueous NaOH (0.5 M), 2 x 50 
ml water, 50 ml ethanol and 50 ml ether. The white 
product was dried under vacuum. Yield: 75% (1.278 g, 
1.86 mmol). Mp.: >350 C. 
1
H NMR (CDCl3, 400 MHz): δ ppm 7.52 (2H, d, J = 7.62 Hz), 7.41 (4H, m), 7.33 (2H, t, J 
= 7.642 Hz), 
31
P NMR (CDCl3, 400 MHz, H3PO4): δ ppm 26.27 (s). 
The synthesis of all three derivatives was confirmed by single crystal X-ray diffraction 
analysis. 
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Table 2.1 The unit cell parameters of 2, 8 and 17. This data served as further confirmation that the synthetic 
procedures were successful. 
Unit cell parameters 2 8 17 
Crystal system monoclinic C monoclinic P monoclinic C 
a (Å) 10.99 11.09 15.30 
b (Å) 26.34 12.17 10.85 
c (Å) 17.09 13.71 20.15 
α (°) 90 90 90 
β (°) 101.13 100.92 108.23 
γ (°) 90 90 90 
 
d. 2,2-Bis(4-formylphenoxy)-4,4,6,6-bis[spiro(2,2-dioxy-1,1-biphenylyl]cyclotri-
phosphazene (3) 
2 (2 g, 3.48 mmol), 4-hydroxybenzaldehyde (0.854 g, 6.96 
mmol) and K2CO3 (2.663 g, 19.28 mmol) were added to 
20 ml THF at 0 °C. The mixture was refluxed for 5 hours 
and the solvent removed under vacuum after the reaction 
was complete. The product was then extracted with 4 x 10 
ml DCM and the solvent subsequently removed under 
vacuum yielding a white powder. The product was 
recrystallised from acetone. Yield: 72% (1.881 g, 2.52 
mmol). Mp.: 220 – 224 C. 
1
H NMR (CDCl3, 300 MHz): δ ppm 7.07 (2H, d, J = 7.80 Hz), 7.31 – 7.41 (4H, m), 7.54 
(4H, t, J = 8.58 Hz), 7.96 (2H, d, 8.19 Hz), 10.01 (1H, s) 
31
P NMR (CDCl3, 300 MHz, 
H3PO4): δ ppm 9.62 – 11.69 (tt), 25.59 – 26.71 (dt). 
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2.7.3 Hexakis(4-hydroxyphenoxy)cyclotriphosphazene38 (11) 
1. Hexakis(4-methoxyphenoxy)cyclotriphosphazene (10) 
A suspension of sodium 4-methoxyphenoxide was 
prepared in 20 ml dry THF by allowing 4-
methoxyphenol (4.274 g, 34.5 mmol) to react with 
1.385 g NaH as a 60 % dispersion in mineral oil. 
This is equivalent to 0.828 g (34.5 mmol) pure NaH. 
The NaH was washed with dry petroleum ether to 
remove the mineral oil. A solution of N3P3Cl6 (2 g, 
5.75 mmol) in 20 ml THF was added dropwise to 
this suspension. On complete addition of the 
phosphonitrilic chloride trimer, the reaction mixture was refluxed for 24 hours with 
stirring. The reaction mixture was cooled and washed with 100 ml water in order to 
precipitate the product as a white powder. Yield: 82% (4.136 g, 4.733 mmol). Mp.: 105 – 
106 C. 
1
H NMR (CDCl3, 400 MHz): δ ppm 3.72 (3H, s), 6.77 (4H, s) 
2. Hexakis(4-hydroxyphenoxy)cyclotriphosphazene (11) 
Hexakis(4-methoxyphenoxy)cyclotriphosphazene (3 
g, 3.43 mmol) was dissolved in 30 ml DCM. A 
solution of BBr3 (2 ml, 20.6 mmol) in 30 ml DCM 
was added dropwise to the solution of the 
cyclotriphosphazene. It was then left to stir for 3 
hours, after which it was poured carefully into 100 
ml of water to precipitate the product. The white 
precipitate was filtered off, washed with water and 
dried. Yield: 85% (2.303 g, 2.92 mmol). 
1
H NMR (DMSO-d6, 400 MHz): δ ppm 6.59 (2H, s), 6.61 (2H, s), 
31
P NMR (DMSO-d6, 
400 MHz, H3PO4): δ ppm 22.32 (s). 
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2.7.4 Hexakis(4-formylphenoxy)cyclotriphosphazene30, 39 (6) 
4-hydroxybenzaldehyde (2.128 g, 17.28 mmol), 
K2CO3 (4.788, 34.56 mmol) and N3P3Cl6 (1.026 g, 
2.88 mmol) were added to 40 ml acetone and refluxed 
for 12 hours. The solution was then filtered and the 
solvent removed under reduced pressure to produce a 
yellow powder. Yield: 57% (1.414 g, 1.64 mmol). 
Mp.: 215 – 220 C. 
 
1
H NMR (DMSO-d6, 400 MHz): δ ppm 6.84 (2H, m), 7.25 (2H, m), 8.31 (1H, s), 
31
P 
NMR (DMSO-d6, 400 MHz, H3PO4): δ ppm 9.68 (s). 
2.7.5 Hexakis(4-fluorophenyl)cyclotriphosphazene20, 30 (12) 
This synthetic procedure was not performed under 
inert conditions. 4-fluorophenol (1.94 g, 17.28 
mmol) and N3P3Cl6 (0.998 g, 2.88 mmol) were 
dissolved in 60 ml acetone. K2CO3 (4.797 g, 
120.96 mmol) was added to this mixture and the 
reaction mixture was refluxed for 12 hours. The 
precipitate was filtered off, washed with DCM and 
combined with the filtrate. The solvent was then 
removed in vacuo. The white powder was 
recrystallised from methanol. Yield: 65% (3.131 g, 
3.91 mmol). Mp.: 129 °C. 
1
H NMR (CDCl3, 400 MHz): δ ppm 6.88 (2H, s), 6.9 (2H, s), 
31
P NMR (CDCl3, 400 MHz, 
H3PO4): δ ppm 9.86 (s). 
Two novel polymorphs of this compound have been isolated in this study. These 
polymorphs will be discussed in detail in chapter 3. 
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2.7.6 Hexakis(4-iodophenyl)cyclotriphosphazene20, 30 (13) 
4-iodophenol (3.844 g, 17.28 mmol) and N3P3Cl6 
(1.007 g, 2.88 mmol) were dissolved in 75 ml 
acetone. K2CO3 (4.821 g, 34.56 mmol) was 
added to this mixture. The mixture was refluxed 
for 2 days. The solvent was evaporated under 
vacuum and the product was extracted with 3 x 
20 ml DCM. The product was further purified by 
recrystallisation from acetonitrile to yield a white 
crystalline powder. Yield: 65% (2.702g, 1.86 
mmol). Mp.: 187.6 °C. 
1
H NMR (CDCl3, 400 MHz): δ ppm 6.62 (2H, d, J = 8.79 Hz), 7.52 (2H, d, 8.79 Hz), 
31
P 
NMR (CDCl3, 400 MHz, H3PO4): δ ppm 9.27 (s). 
2.7.7 Hexakis(4-bromophenyl)cyclotriphosphazene20, 30(14) 
4-bromophenol (3.030 g, 17.28 mmol) and K2CO3 
(4.779 g, 34.56 mmol) were added to 50 ml 
acetone. N3P3Cl6 (1.011 g, 2.88 mmol) in 10 ml 
acetone was added to this mixture. The reaction 
mixture was refluxed for 2 days. The solvent was 
removed under vacuum and the product purified by 
recrystallisation from acetonitrile to yield a white 
crystalline powder. Yield: 79 % (2.684 g, 2.3 
mmol). Mp.: 176.8 °C. 
1
H NMR (CDCl3, 400 MHz): δ ppm 6.75 (2H, d, 8.79 Hz), 7.33 (2H, d, 8.89 Hz), 
31
P 
NMR (CDCl3, 400 MHz, H3PO4): δ ppm 9.29 (s). 
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2.7.8 Hexakis(4-chlorophenyl)cyclotriphosphazene20, 30 (15) 
4-chlorophenol (2.240 g, 17.28 mmol) and 
K2CO3 (4.793 g, 34.56 mmol) were stirred 
together in 50 ml acetone. N3P3Cl6 (1.004 g, 2.88 
mmol), dissolved in 10 ml acetone, was added to 
the mixture and refluxed for 1 day. The solvent 
was removed under vacuum and the product 
extracted with DCM. The product was further 
purified by recrystallisation from acetonitrile. 
Yield: 76 % (1.982 g, 2.2 mmol). Mp.: 152 °C  
1
H NMR (CDCl3, 400 MHz): δ ppm 6.68 (2H, d, 8.20 Hz), 7.17 (2H, d, 8.40 Hz), 
31
P 
NMR (CDCl3, 400 MHz, H3PO4): δ ppm 9.59 (s). 
2.7.9 Tris(o-phenylenedioxy)cyclotriphosphazene5, 40 (16) 
Catechol (0.982 g, 8.63 mmol) was dissolved in 80 
ml dry THF. K2CO3 (2.400 g, 17.26 mmol) was 
added to this solution and the solution was then 
allowed to stir. N3P3Cl6 (1.015 g, 2.88 mmol) was 
dissolved in 20 ml THF and added dropwise to the 
catechol/K2CO3 suspension. The reaction mixture 
was refluxed overnight and the solvent then removed 
under reduced pressure. The residue was washed 
with 2 x 20 ml water and methanol, yielding a white powder. Yield: 44% (0.577 g, 1.26 
mmol). 
1
H NMR (CDCl3, 400 MHz): δ ppm 7.02 – 7.06 (2H, m), 7.08 – 7.12 (2H, m), 
31
P NMR 
(CDCl3, 400 MHz, H3PO4): δ ppm 33.83 (s). 
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2.7.10 Hexakis(4-cyanophenoxy)cyclotriphosphazene24 (5) 
A mixture of 4-cyanophenol (2.071 g, 17.28 
mmol) and K2CO3 (4.804 g, 34.56 mmol) was 
prepared in 80 ml THF. N3P3Cl6 (1.030 g, 2.88 
mmol) in 15 ml THF was added dropwise to this 
mixture. The reaction mixture was refluxed for 6 
hours with vigorous stirring. The solvent was 
removed in vacuo and the residue dispersed in 100 
ml water. The white product was separated by 
filtration and allowed to dry. Yield: 94 % (2.284 
g, 2.707 mmol). Mp.: 263 – 265 C. 
1
H NMR (DMSO-d6, 400 MHz): δ ppm 7.16 (2H, d, 8.79 Hz), 7.82 (2H, d, 8.79 Hz), 
31
P 
NMR (DMSO-d6, 400 MHz, H3PO4): δ ppm 8.51 (s). 
2.7.11 Hexakis(4-pyridyloxy)cyclotriphosphazene21 (4) 
4-hydroxypyridine (0.826 g, 8.64 mmol) and K2CO3 
(1.818 g, 12.96 mmol) were added to 50 ml THF. 
N3P3Cl6 (0.503 g, 1.44 mmol) was added to this 
mixture. The mixture was stirred for two and a half 
days at room temperature, after which it was 
refluxed for approximately 6 hours. The solvent was 
removed under vacuum and the residue washed with 
100 ml water. The product was isolated by filtration 
and dried to yield a light yellow product. Yield: 89% 
(0.897 g, 1.28 mmol). Mp.: 163 – 165 C. 
1
H NMR (CDCl3, 400 MHz): δ ppm 6.93 (2H, d, 6.44 Hz), 8.50 (2H, d, 6.25 Hz), 
31
P 
NMR (CDCl3, 400 MHz, H3PO4): δ ppm 7.30 (s). 
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Chapter 3   
Two novel  polymorphs of   
hexakis(4-f luorophenoxy)cyclotriphosphazene  
Polymorphism in cyclotriphosphazenes is not an unheard of phenomenon as it has been 
observed before, among others, in the case of 2,2-dichloro-4,4:6,6-bis(2,2-
dimethlypropane-1,3-dioxy)-cyclotriphosphazene.
1, 2
 During the investigation into co-
crystal formation with cyclotriphosphazenes, two novel polymorphs of the known 
hexakis(4-fluorophenoxy)cyclotriphosphazene (12) were isolated. First, a novel triclinic 
phase of the fluorophenoxy derivative was identified. Upon further investigation during 
variable temperature studies, another phase was discovered. In this case, the known 
monoclinic P phase converts to a monoclinic C phase at high temperatures. The known 
crystal structure of 12 will be discussed first.
3
 Crystal data for this structure was 
previously collected at room temperature. The structure will be compared to the crystal 
structure that was collected at 100 K to study the effect temperature has on the 
conformation of the molecule. The structure of the novel triclinic phase will then be 
discussed in detail and compared to that of the monoclinic phase. Differential scanning 
calorimetry (DSC) and powder X-ray diffraction (PXRD) studies were also performed on 
these polymorphs to explore the phase transition that occurs and to determine whether 
these are monotropic or enantiotropic polymorphs. Interesting results obtained from these 
experiments prompted further analysis by variable temperature single crystal X-ray 
diffraction (SCD). Analysis by hot stage microscopy investigated the phase transformation 
from the triclinic to monoclinic phase and determined that it did not occur in a single 
crystal to single crystal fashion. Variable temperature SCD and PXRD studies investigated 
the transformation from the monoclinic P to monoclinic C form. 
3.1. Polymorphism 
McCrone
4
 defined polymorphism as the capability of the same chemical compound to 
crystallise “as more than one distinct crystal species”. This implies that the same 
compound can pack in different ways in the solid state. This phenomenon has been of 
interest for many years, especially in the pharmaceutical industry. The properties of a 
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certain compound are greatly affected by its packing arrangement in the solid state, 
therefore a change in the structure can give the same chemical compound new properties.
5
 
This has major implications for patents on drugs where a new polymorph might, for 
example, have better solubility properties.
4, 5
 The polymorph is considered to be a new 
compound; therefore a rival company can attain a patent for it subsequently costing other 
companies millions.
6, 7
 
Desiraju
8
 posed an excellent question regarding the abundance of polymorphism: 
“Why should any molecule crystallise in more than one form especially when it appears 
that molecular recognition is such a subtle and specific event that demands an exact 
matching in geometrical and chemical terms of the various interacting molecules?” 
Therefore, studying this phenomenon is of utmost importance. Studying these systems 
allow crystal engineers to fundamentally understand what controls molecular assembly 
and, in turn, use these principles to engineer specific compounds with specific properties. 
Crystallisation is a process that is dependent on the formation of nucleation sites within 
the crystallisation vessel. This process is dependent on the temperature, solvent system 
and the rate at which crystallisation is allowed to occur.
9
 Changing these experimental 
conditions can lead to the formation of polymorphs. 
Molecular structure is determined by bond lengths, bond angles and torsion angles.
6
 These 
torsion angles allow some molecules a large degree of freedom of movement,
9
 which 
allows them to adopt different conformations in the solid state.
10
 This is termed 
conformational polymorphism. These types of polymorphs contain a large amount of 
information regarding the range and values of a torsion angle.
6
 However, the more 
important contribution is that they provide the opportunity to study the relationship 
between intra- and intermolecular energies.
6
 This leads to insight into when the lowest 
energy conformation of the single molecule will be sacrificed for the greater good: more 
efficient packing in the solid state that could lead to a lower energy state. Molecules that 
display a large variation in the torsion angles stand a greater chance to exhibit 
polymorphism.
7
 This is because the different conformations that the molecule adopts can 
lead to different hydrogen-bonding and close-packing styles.
7
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In some cases two or more polymorphs may appear under the same conditions, often 
crystallising in the same vessel.
6
 This is defined as concomitant polymorphism. This 
phenomenon has also been of great interest to the supramolecular community.
11
 Not only 
does it give crystal engineers an indication of the role of kinetics in the crystallisation 
process, but it provides excellent computational models in the quest to predict crystal 
structures.
6, 12
 This is due to the fact that concomitant polymorphs are almost energetically 
equivalent. Since there appear to be conditions that both polymorphic forms favour, 
studying concomitant polymorphs and fine-tuning the conditions that favour one above the 
other, leads to a wealth of information regarding the control of polymorphic 
crystallisation.
6
  
The relationship between two polymorphs can be classified into two systems: 
enantiotropic or monotropic. This classification is related to the Gibbs free energy (G) of 
the system. G will be at a minimum for the thermodynamically stable phase, whereas for 
the metastable phase G will be higher.
13
 With an increase in the temperature, the 
polymorph with higher entropy will become the more stable form. The distinction between 
enantiotropic and monotropic conversion is dependent on where this transformation takes 
place. In a monotropic system all the polymorphs can be found below their particular 
melting points.
14
 This means that below the melting point only one of the two forms is 
stable and the other form is metastable.
13
 The metastable form can convert to the 
thermodynamically more stable form, but this process is irreversible and the transition 
normally occurs above the melting points.
15
 In the case of enantiotropic polymorphs, the 
different polymorphs can also be present below the melting point, but there is a transition 
temperature (Tt) where a conversion from one form to the other can occur.
13
 However, this 
process is reversible.
13, 14
 At temperatures above Tt polymorph A is more stable than 
polymorph B, and at temperatures below Tt polymorph B is more stable than A. 
3.2. Single crystal X-ray diffraction studies of the monoclinic phase of hexakis(4-
fluorophenoxy)cyclotriphosphazene 
During the course of this study, a novel polymorph of 12 was isolated. Under certain 
crystallisation conditions (which will be discussed in section 3.3.1) a triclinic phase was 
isolated, as well as the known monoclinic phase that was first characterised by Allcock.
3
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The monoclinic phase will from here on be referred to as M, and the triclinic phase will be 
referred to as T.  
The structure published by Allcock
3
 crystallises in the monoclinic crystal system in the 
space group P21/n (Figure 3.1). The phosphazene ring is slightly puckered, with the p-
fluorophenyl rings perpendicular to the phosphazene ring. The molecules close-pack 
through intermolecular stacking of the p-fluorophenyl groups
3
 and this leads to the 
formation of ribbons throughout the crystal structure (Figure 3.1b). These ribbons stack 
one behind the other to fill all possible voids. 
The data for M was originally collected at room temperature (RT, referred to as MRT); 
therefore a low temperature structure (referred to as M100K) was also collected to 
determine if there are any structural differences between the room temperature and low 
temperature structures. It would be logical to assume that there would be minor 
differences, mostly due to movement of the atoms at a higher temperature because they 
have more kinetic energy, consequently moving more. It was rather surprising to discover 
that the two structures are nearly identical regarding the position of the p-fluorophenyl 
rings and the torsion angles in the molecule. Figure 3.2 illustrates the similarities in the 
conformation of the two molecules. In Figure 3.2b it is evident that the unit cells are not 
an exact match. But the differences in the unit cell parameters can be attributed to the 
large temperature difference between the two data collections. Upon cooling, the axes and 
a) b) 
Figure 3.1 a) The structure of the known fluorophenyl derivative, M. (b) Ribbon-like packing of M, 
viewed down the crystallographic b-axis. 
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β angle of MRT become smaller. The unit cell parameters of the two structures can be 
found in Table 3.1. 
 
 
 
 
 
 
 
 
 
Table 3.1 The unit cell parameters of MRT and M100K. 
Parameters MRT M100K 
Crystal system Monoclinic P Monoclinic P 
Space group P21/n P21/n 
a (Å) 20.860(5) 20.323(2) 
b (Å) 8.085(1) 8.051(8) 
c (Å) 21.813(5) 21.694(2) 
α (°) 90 90 
β (°) 104.62(3) 103.831(1) 
γ (°) 90 90 
Z 4 4 
R1 ([I > 2(I)] 5.68 3.44 
a) b) 
Figure 3.2 (a) The structure overlay of MRT (in red) and M100K (in blue). (b) The packing overlay of MRT 
and M100K. The difference in the unit cell parameters is due to the temperature as there is a contraction of the 
unit cell on cooling. This results in the offset of the overlay. 
a 
c 
0 
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The simulated powder patterns of the room temperature and 100 K crystal structures were 
also compared for further validation that they are the same. The powder patterns were 
simulated using Mercury
16-19
 and visualised in X’Pert HighScore (Figure 3.3). 
At first glance the powder patterns of the two structures seem identical (Figure 3.3a). On 
closer inspection, minor differences in the patterns become apparent – especially in the 
region between 2θ = 19 ° and 2θ = 30 ° (Figure 3.3b). A general shift in the pattern is 
expected due to the change in temperature. From Figure 3.3 it is clear that the peaks from 
M100K are shifted to the right, relative to the peaks of MRT. Further analysis shows that 
some peaks disappear (i, ii, v), while the shape of other peaks change (iii, iv). This could 
be attributed to the slight changes in the bond lengths of the molecules and the molecules 
moving closer to each other on cooling of the crystal. The slight shortening of the unit cell 
axes and β angle seen in Table 3.1 and Figure 3.2b could also cause the slight differences 
in the peak positions of the simulated powder patterns. 
To ensure that there was not some anomaly in the data collected at low temperature, 
another data collection was performed on a crystal of the monoclinic phase, but this time it 
was carried out at room temperature. The powder patterns of the room temperature 
structures were once again simulated by Mercury
16-19
 and analysed using X’Pert 
HighScore (Figure 3.4). In this case, the two simulated patterns overlay perfectly. The 
peak shapes are consistent in both traces and the each peak correlates perfectly between 
the two patterns.  
The difference in the patterns of MRT and M100K could indicate that the molecules in the 
crystal undergo a conformational change between RT and 100 K. This was investigated 
using variable temperature (VT) PXRD and is discussed in sections 3.4 and 3.6. 
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Position [°2Theta] (Copper (Cu))
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0
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 M (RT)  simulated
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Position [°2Theta] (Copper (Cu))
20 25 30
Counts
0
2000
4000
6000
0
2000
4000
6000
 M (RT)  simulated
 M (100 K) simulated
i ii iii iv v 
Figure 3.3 (a) Comparison of the simulated powder patterns of MRT (in red) and M100K (in blue). There appears 
to be a very good correlation between the patterns. (b) Small differences are noted where peaks are missing (i, 
ii, v) and where the peak shape has changed (iii, iv). 
a) 
b) 
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3.3. The novel triclinic phase of 12 
This section will describe the studies performed on the triclinic phase (T) of the 
fluorophenoxy derivative. First, the crystallisation experiments that were conducted from 
which T was isolated will be discussed. Thereafter, the structure of T will be described 
and the monoclinic phase (M) and T will be compared. PXRD, single crystal X-ray 
diffraction and DSC studies will also be discussed. 
3.3.1. Crystallisation experiments 
The aim of this study was to investigate co-crystal formation with cyclotriphosphazenes. 
The halophenoxy derivatives were used to determine whether halogen bonding would be a 
successful driving force for co-crystallisation with small molecules containing either 
halogen or nitrile groups. The halophenoxy derivatives are not air sensitive compounds, 
therefore crystallisations were not performed under inert conditions. The fluorophenoxy 
derivative and the co-crystallisation agent were dissolved separately in a suitable solvent, 
added together and left to stand until crystals formed. Table 3.2 outlines some of the 
Position [°2Theta] (Copper (Cu))
5 10 15 20 25 30
Counts
0
5000
0
5000
 Published monoclinic structure (RT)
 Newly collected monoclinic structure (RT)
Figure 3.4 The simulated powder patterns of the monoclinic phase. The top diffractogram (red) is the 
simulated pattern of the structure published by Allcock
3
 that was collected at room temperature. The bottom 
diffractogram (green) is the simulated pattern of the data collected on a crystal of the monoclinic phase in 
this study, also at room temperature. 
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crystallisations that were performed as well as the solvent systems used in each case. The 
ratio of cyclotriphosphazene to co-crystallisation agent is also indicated, as well as which 
polymorph was obtained from each co-crystallisation experiment. 
Table 3.2 Co-crystallisation experiments conducted with hexakis(4-fluorophenoxy)cyclotriphosphazene. 
Co-crystallisation agent 
Ratio of 
12:co-crystal 
former 
Solvents Polymorph 
4-bromobenzonitrile  1:3 acetonitrile/DCM triclinic P 
α-dibromo-p-xylene  1:1 acetonitrile/DCM triclinic P 
α-dibromo-o-xylene  1:1 acetonitrile/DCM triclinic P 
imidazole  1:2 THF triclinic P 
pyridine  1:2 THF monoclinic P 
3,4-lutidine  1:2 THF monoclinic P 
cobalt(II)acetate  1:1 THF/methanol triclinic P 
copper(II)acetate  1:1 THF/methanol triclinic P 
From Table 3.2 it is clear that there does not seem to be a significant pattern regarding 
which polymorph crystallises from which co-crystallisation conditions. Crystallisations 
were therefore set up again with the co-crystallisation agents and it was noted that the 
vials from which solvent evaporated the quickest, tended to form the triclinic phase. The 
fast evaporation rate could possibly trap the molecule in a conformation that does not pack 
efficiently. To ensure that this was definitely not a co-crystallisation agent effect, 
crystallisations were set up from different pure solvents and solvent mixtures. The 
solvents are however quite volatile, therefore evaporation tended to occur quickly. The 
results are summarised in Table 3.3. 
N Br
Br
Br
Br
Br
N
HN
N
N
Co++
O
O- O
-O
Cu++
O
O- O
-O
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Table 3.3 Crystallisation experiments of 12 from pure solvents. 
Solvents Polymorph Conditions 
acetonitrile/DCM triclinic P 
Vial covered with parafilm, placed in 
a warm environment 
acetonitrile triclinic P 
DCM triclinic P  
THF/methanol triclinic P 
THF monoclinic P 
It can be concluded that the triclinic form will crystallise from most volatile solvents, 
especially when evaporation occurs at a high rate. However, it appears that the monoclinic 
form will crystallise from THF even under fast evaporation conditions. 
3.3.2. Single crystal X-ray diffraction studies of the triclinic phase, T 
The novel polymorph that was isolated crystallises in the triclinic crystal system in the 
space group P. The unit cell parameters for the triclinic polymorph T (collected at 100 K 
and room temperature) can be found in Table 3.4. In this molecule, one of the 
fluorophenoxy rings has rotated away from the other fluorophenoxy ring (shown in red in 
Figure 3.5b), essentially disrupting the close contact (3.735 Å between the centroids) 
between two of the fluorophenoxy rings in the molecule that is seen in M (Figure 3.5a). 
Another fluorophenoxy ring is now twisted in the opposite direction (shown in blue in 
Figure 3.5b).  
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Table 3.4 The unit cell parameters of M and T at 100 K and room temperature. 
Parameters M100K T100K TRT 
Crystal system Monoclinic P Triclinic P Triclinic P 
Space group P21/n P P 
a (Å) 20.323(2) 9.444(9) 9.596(2) 
b (Å) 8.051(8) 9.925(1) 10.056(2) 
c (Å) 21.694(2) 18.669(2) 18.910(3) 
α (°) 90 103.683(1) 103.575(2) 
β (°) 103.831(1) 96.009(1) 97.097(2) 
γ (°) 90 91.803(1) 93.100(2) 
Z 4 2 2 
R1 ([I > 2(I)] 3.44 3.87 4.67 
 
 
 
 
 
 
 
 
 
  
a) Monoclinic b) Triclinic 
Figure 3.5 (a) The known monoclinic phase M, with two fluorophenoxy rings forming a close contact 
(3.735 Å between the centroids) in the molecule. (b) In the triclinic phase this close contact is disrupted 
(shown in red). The fluorophenoxy ring shown in blue has also twisted. 
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This causes the molecules to pack in columns rather than the ribbon-like sheets of the 
monoclinic phase, as can be seen in Figure 3.6a. These columns are related by an 
inversion centre. This means that the symmetry operator x,y,z describes the green 
molecules, and the symmetry operator 1-x, 1-y, 1-z describes the orange molecules 
(Figure 3.6b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 3.6 (a) The molecules in the triclinic phase pack in columns. (b) These columns are related by 
symmetry operations, where the orange molecules are the inversion of the green molecules. This packing 
diagram is viewed down the b-axis. 
a) 
b) 
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In order to better understand the intermolecular interactions at play in each polymorph, 
CrystalExplorer 2.1
20-24
 was used to visually represent these interactions. This program 
generates a Hirshfeld surface.
25
 The Hirshfeld surface defines the space occupied by a 
molecule within a crystal structure.
26
 It partitions the crystal space into molecular volumes 
that are smooth and interlock, but do not overlap.
27
 Inside the Hirshfeld surface the 
electron distribution due to a sum of spherical atoms for the molecule (promolecule) 
dominates the corresponding sum over the crystal (procrystal).
27
 The Hirshfeld surface is 
then implied where the ratio of promolecule to procrystal electron density is equal to 0.5.
27
 
The Hirshfeld surface visualises the relationship between different atoms and 
intermolecular contacts in the crystal.
27
 This information is then used to generate a 
fingerprint plot that creates a visual representation of possible interactions or contacts in 
the crystal structure. These plots map the distance from the Hirshfeld surface to either the 
nearest nucleus inside the surface (di) or outside the surface (de).
26
 This means that 
fingerprint plots are used to show the relation of di and de. Fingerprint plots are also 
especially useful in the analysis of polymorphs, as they are highly dependent on the 
environment surrounding the molecule.
26
 Therefore a change in the packing arrangement 
will have a large effect on the fingerprint plot. Fingerprint plots were generated for both 
the known monoclinic and triclinic form of 12 (Figure 3.7). 
 
Figure 3.7 Fingerprint plots of the monoclinic and triclinic forms of hexakis(4-fluorophenoxy)-
cyclotriphosphazene 
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It is clear from Figure 3.7 that there is a large difference in the intermolecular interactions 
present in each crystal structure. The change in the conformation of the fluorophenoxy 
groups in the triclinic form has a large influence on the intermolecular interactions that 
can now be formed. But this can be better understood by looking at a breakdown of the 
fingerprint plots (Figure 3.8). These fingerprint plots will highlight specific interactions or 
close contacts in each crystal structure. 
The first intermolecular interaction that will be discussed is the F···F interaction. It is a 
somewhat controversial interaction and mostly believed to be very weak if it is in fact 
observed.
28
 According to Ramasubbu et al, 
29
 F···F interactions can be classified into two 
types, namely type I which is caused by close packing within the crystal structure, and 
therefore not a true intermolecular interaction, and type II which is caused by polarisation 
of the fluorine atoms.
28, 29
 Type II is considered to be an intermolecular interaction. While 
studying the fingerprint plot (Figure 3.8) of the possible F···F interactions, along with the 
crystal structure of both forms, it is evident that the F···F contacts are a result of close 
packing in the crystal structure. Distances between F atoms are longer than 3 Å. This also 
explains why this type of contact occurs more readily in the monoclinic phase than the 
triclinic phase. In the monoclinic phase, the molecules close pack in such a way, due to the 
molecular conformation, that more fluorine atoms are close together. However, in the 
triclinic structure, due to the twisting of two of the fluorophenoxy rings, the shape of the 
molecule is now so awkward that the fluorophenoxy groups cannot pack as closely as 
before. Although there are examples in the literature
30
 of F···F interactions, they do not 
feature in these two polymorphs. 
The F···H interaction is considered to be a type of intermolecular interaction for distances 
up to 2.9 Å,
28
 and studying the fingerprint plots and the crystal structures, it is evident that 
this is a much more robust interaction in these two crystal structures. It even outweighs the 
occurrence of C···H interactions (π-stacking interactions). From Figure 3.8, it is also clear 
that this is the dominant interaction, especially in the case of the triclinic form where 
29.6% of the possible intermolecular contacts are F···H interactions. 
The remaining close contacts are mainly O···H, N···H and H···H close contacts in both 
structures. 
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F···F contacts 
H···F interactions 
C···H interactions 
F···F contacts 
H···F interactions 
C···H interactions 
Monoclinic Triclinic 
Figure 3.8 Distribution of intermolecular interactions in each polymorph. This shows that in both 
structures H···F interactions are the dominating intermolecular interaction. In the monoclinic phase C···H 
interactions are also abundant. This is due to π-π stacking interactions. 
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PXRD analysis was used to compare the low temperature (100 K) and room temperature 
structures of the triclinic form. These patterns correspond very well, with minor 
differences in peak form and peak splitting, which could be due to the change in 
temperature and vibration of the molecule (Figure 3.9). 
 
 
 
 
 
 
 
 
PXRD analysis of a vial of crystals, from which the triclinic form was isolated, showed 
that only the triclinic form crystallised in the vial (Figure 3.10). This implies that the two 
phases crystallise separately in pure phases, and not as concomitant polymorphs. 
 
 
 
 
 
 
 
 
Position [°2Theta] (Copper (Cu))
10 20 30
Counts
0
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0
5000
 Triclinic phase at 100K (simulated)
 Triclinic phase at RT (simulated)
Figure 3.9 The simulated powder patterns of the crystal structures at 100 K (blue) and room temperature 
(red). 
Position [°2Theta] (Copper (Cu))
10 15 20 25 30 35
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0
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10000
 Triclinic phase at RT (simulated)
 Triclinic phase at RT (experimental)
Figure 3.10 The simulated and experimental patterns of the triclinic phase. The two patterns 
correspond very well, indicating that all the crystals in the vial are of the triclinic phase. 
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3.4. Differential scanning calorimetry (DSC) and PXRD studies of crystal forms 
M and T 
Polymorphic compounds often exhibit interesting properties that differ vastly from each 
other. In-depth analysis of polymorphic compounds is therefore very important. DSC 
analysis was performed on both crystal forms, M and T (Figure 3.11 and Figure 3.12). 
DSC analysis can help to identify whether two polymorphs are part of a monotropic or 
enantiotropic system. A DSC plot can give an indication of whether or not the different 
polymorphic forms can interconvert, i.e. change from the triclinic to the monoclinic form 
or vice versa – depending on which polymorph is the more stable form. This analysis will 
also be able to show which polymorphic form, M or T, is in fact the more stable form. 
In each case, the sample was heated to the desired temperature at 10 °C/minute and then 
cooled to the desired temperature at 5 °C/minute. The sample was then heated to room 
temperature at 10 °C/minute. 
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Figure 3.11 DSC of M. Melting of the monoclinic form occurs at the onset temperature of 128.4 °C as 
an endothermic event. Recrystallisation occurs at 53.4 °C as an exothermic event. 
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The monoclinic polymorph melts at 128.4 °C, after which it recrystallises at 53.4 °C 
(Figure 3.11). The triclinic form shows two events in the DSC – the first occurs at 98.4 °C, 
which could indicate a phase change (Figure 3.12). The second event occurs at the same 
temperature where the monoclinic form undergoes melting. This could mean that at 98.4 
°C the triclinic form converts to the monoclinic form, then melts at 128.7 °C. On cooling, 
there is only one recrystallisation event at 45.9 °C.  
 
When the DSC run is cycled, i.e. the sample is heated up to 140 °C, cooled down to -60 
°C and heated again to 140 °C, the first event does not occur again (Figure 3.13). This 
indicates that the monoclinic form does not convert back to the triclinic form. 
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Figure 3.12 DSC of the triclinic form. The first event occurs at 98.4 °C and the second event at 128.7 °C. 
The second event corresponds to the melting of the monoclinic form. 
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Variable temperature PXRD (VT PXRD) analysis was used to further study this 
phenomenon (Figure 3.14). Crystals of the triclinic form were ground to a powder and 
placed in a capillary. The sample in the capillary was allowed to equilibrate at 25 °C and a 
measurement was taken. The sample was then heated and measurements were taken at 
approximately 20 °C increments. In the region of the phase transformation (85 °C to 115 
°C) measurements were taken every 5 °C. Thereafter measurements were taken at 10 °C 
intervals up to 135 °C. The sample was cooled and measurements were taken at 
approximately 20 °C intervals to 25 °C. After each temperature change, the sample was 
allowed to equilibrate for two minutes.  
PXRD analysis indicates that the triclinic structure undergoes a phase change between 90 
°C and 95 °C, where it converts to the monoclinic phase. The discrepancy in the 
temperatures between the DSC and PXRD results could be due to the sample size, or the 
Figure 3.13 The cycled DSC run of T. The sample was heated to 140 °C, cooled to -60 °C and then these 
two steps were repeated. The DSC trace shows that the triclinic form does not appear again in the second 
cycle after the phase transformation and the melt. 
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temperature calibration of the instruments. Melting occurs after 125 °C and on cooling 
only the monoclinic phase recrystallises. There appear to be a number of peaks missing in 
the pattern after the sample melted at 135 °C, but this could be due to preferred orientation 
as the sample is now in crystalline form as opposed to the fine powder it was before. 
Preferred orientation occurs when crystals orientate themselves along the same flat surface 
which causes that crystal surface to be preferentially exposed to the X-ray beam. This 
leads to increased intensity in some reflections, whereas other planes get little or no 
exposure, causing a decrease or absence of a peak in the powder pattern.
31
 
 
 
 
 
 
 
Figure 3.14 The PXRD shows that T converts to M between 90 and 95 °C. Between 125 and 135 °C the 
sample melts and recrystallises as the monoclinic form. It does not convert back to T on cooling. 
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As further confirmation that T can only convert to M, a VT PXRD study was carried out 
on the monoclinic phase (Figure 3.15). This clearly shows that at no point does the 
monoclinic form convert to the triclinic form. This indicates that the conversion from T to 
M is an irreversible phase change and that the triclinic form is the metastable polymorph. 
As was mentioned previously, the change in the pattern after the melt could be due to 
preferred orientation. 
 
 
 
  
Figure 3.15 The VT PXRD experiment that was done on the triclinic form was repeated on the monoclinic 
form. There does not appear to be a significant change in the patterns, indicating that no phase change 
occurred. This implies that the monoclinic form is the more stable form of the two polymorphs. 
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3.5. Hot stage microscopy 
Hot stage microscopy allows the direct observation of the crystals during heating. The 
crystals are placed on a slide and covered with a cover slip. In some cases the crystals can 
be placed in silicone oil. This is especially useful if the crystals contain solvent or gas 
molecules – when the gas or solvent starts to escape, it can be observed in the form of 
bubbles in the oil. The crystals of M and T do not contain any solvent or gas therefore it 
was not deemed necessary to place them in oil. The crystals of T were heated to 140 °C at 
10 °C per minute and pictures were taken every thirty seconds.  
Figure 3.16 illustrates how the phase change takes place and the change it causes in the 
crystal. At first the crystals are clear and remain clear up to 100 °C. During the phase 
transition around 100 °C the crystals start to turn opaque and at 130 °C one of the crystals 
has already melted. Hot stage microscopy clearly shows that the triclinic phase does not 
melt for the conversion to occur. However, once the crystals have melted they can only 
recrystallise in the monoclinic phase, according to VT PXRD and DSC analyses. This 
system can therefore be classified as a case of monotropic polymorphism. The transition is 
from a less stable phase, the meta-stable phase (T), to the stable phase (M). This transition 
is also not reversible, which is why it is classified as a monotropic phase transformation. 
Single crystal X-ray diffraction studies were attempted on the crystals before and after 
phase transformation to study the conformational changes in the molecule. This will be 
discussed in section 3.6.1. 
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25 °C 
100 °C 
130 °C 
Figure 3.16 The crystals of the triclinic phase are clear until the phase transformation at 100 °C, after 
which they become opaque. Cracking of the crystal also appears in places. At 130 °C the crystals begin 
to melt. 
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3.6. Investigation into the phase transformation of the monoclinic P polymorph 
3.6.1. Variable temperature studies on the conversion from triclinic to 
monoclinic 
During the investigation into the relationship between the triclinic and monoclinic phase 
and studying the phase transformation from T to M, an interesting discovery was made 
regarding the behaviour of the crystals on heating. A sample of the triclinic phase was 
heated to 118 °C – just after the phase transition, but before melting occurred – then 
cooled to -40 °C and heated again to room temperature. Figure 3.17 shows that the 
conversion of the triclinic form to the monoclinic form takes place around 100 °C, as was 
previously seen. A new exothermic event occurs at -22.1 °C, which could indicate another 
phase change.  
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Figure 3.17 The sample was heated to 118 °C, cooled to -40 °C and heated to room temperature again. 
On cooling, an exothermic event occurs at -22.9 °C, possibly indicating a phase change. 
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In order to investigate whether the event on cooling is related to the behaviour of the 
triclinic form or the monoclinic form, the DSC run was cycled. The sample was heated to 
118 °C, cooled to -40 °C, heated to 118 °C again, and then cooled again. The results are 
illustrated in Figure 3.18. It appears that after the phase change around 100 °C, the 
triclinic form does not reappear in the second cycle. This can be concluded from the fact 
that the peak at 96.1 °C (Figure 3.18) is not seen in the second cycle. The peak at 96.1 °C 
is the temperature where the triclinic form T converted to the monoclinic form M. 
Therefore, the events occurring around -20 °C and 0 °C can be attributed to the 
monoclinic form of the crystal structure. 
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Figure 3.18 The endotherm indicating the phase transition from triclinic to monoclinic does not appear on 
heating the sample for the second cycle to 118 °C. The events around -20 °C do however reoccur in the 
second cycle. 
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The events at -20 °C and 0 °C only occur if the triclinic phase is first heated to the point 
after the phase transformation. If the triclinic phase is cooled to -40 °C first, the peaks do 
not appear. Although, once the sample has been heated again the peaks reappear on 
cooling in the second cycle (Figure 3.19). 
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Figure 3.19 The peaks do not appear if the sample of the triclinic phase is cooled first. The peaks 
reappear once the sample has been heated to the transition point and then cooled. 
Stellenbosch University http://scholar.sun.ac.za
C h a p t e r  3  –  P o l y m o r p h i s m  i n  c y c l o t r i p h o s p h a z e n e s  
 
27 | 3  
 
VT PXRD analysis once again supplemented DSC analysis to attempt to understand the 
exo- and endothermic events around -20 °C. The triclinic phase was heated to the 
temperature of the conversion, and then cooled to -45 °C (Figure 3.20). At first glance it 
appears that nothing out of the ordinary is taking place. The triclinic phase once again 
converts to the monoclinic phase between 90 and 95 °C and remains monoclinic on 
cooling to -45 °C. On closer inspection, small differences in the fine structure of the 
patterns taken at 95, -45 and 25 °C become apparent (indicated in Figure 3.20).  
 
VT PXRD analysis was also done in the range between 0 and -45 °C to investigate the 
changes taking place. These are analysed in Figure 3.21. On expansion of the patterns, the 
fine structure differences become more apparent (Figure 3.21b). In some cases peaks that 
were split become one and sharpen. It appears to be a reversible process, as peaks that had 
become one and sharpened at -45 °C, are once again split at -25 °C. 
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Figure 3.20 The conversion from triclinic to monoclinic takes place between 90 and 95 °C. At -45 °C there 
appears to be minor differences in the fine structure of the powder pattern compared (as indicated) to the 
monoclinic phases at 95 and 25 °C. 
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Figure 3.21 (a) Low temperature powder patterns of M after converting from T to M. (b) The fine 
structure differences include peak splitting and peaks that become one. This appears to be reversible, as the 
patterns at -45 °C revert to that of the patterns at -25 °C when the sample is slowly heated again. 
Position [°2Theta] (Copper (Cu))
10 15 20 25 30 35
Counts
0
10000
0
10000
0
20000
0
20000
0
20000
0
10000
0
10000
 -20.0°C
 -25.0°C
 -35.0°C
 -45.0°C
 -35.0°C
 -25.0°C
 -20.0°C
Position [°2Theta] (Copper (Cu))
20 25 30
Counts
0
10000
0
10000
0
20000
0
20000
0
20000
0
10000
0
10000
 -20.0°C
 -25.0°C
 -35.0°C
 -45.0°C
 -35.0°C
 -25.0°C
 -20.0°C
a) 
b) 
Stellenbosch University http://scholar.sun.ac.za
C h a p t e r  3  –  P o l y m o r p h i s m  i n  c y c l o t r i p h o s p h a z e n e s  
 
29 | 3  
 
Further single crystal X-ray diffraction studies were performed with the goal of obtaining 
structural data to explain these observations. First a room temperature structure of the 
triclinic form was obtained. The crystal was then heated to the phase transformation 
temperature and another dataset was collected. This procedure was repeated at -15, -45 
and -173 °C. Unfortunately, after heating the crystal to 112 °C to induce the phase change, 
the crystal became dark and it no longer diffracted. Cooling the crystal did also not 
improve the situation, as it still did not diffract. Around 0 °C it turned slightly opaque, and 
by -15 °C it was almost light blue. At -45 °C it was more opaque than before, but still did 
not diffract. At -173 °C (100 K), the crystal was completely white and appeared to be 
cracked inside. Crystal videos were taken after every temperature step to record what was 
happening to the crystal. Selected highlights of the videos are shown in Figure 3.22. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-173 °C 
RT 112 °C 
-15 °C -45 °C 
-173 °C Figure 3.22 The changes the 
triclinic crystal undergoes on 
heating and then cooling. 
Initially the crystal is clear and 
diffracts well at room 
temperature. At 112 °C the 
crystal undergoes the phase 
change, darkens and no longer 
diffracts. On cooling, the crystal 
becomes opaque and still does 
not diffract. 
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3.6.2. Variable temperature studies of the transformations in the monoclinic 
phase, M 
Since it was not possible to collect single crystal X-ray diffraction data observed in the 
DSC and VT PXRD of the triclinic crystals, the same series of experiments were 
conducted on the monoclinic crystals. This was done to investigate whether the events 
observed in the DSC and PXRD data only occurred with the triclinic form. DSC analysis 
was first performed on a few crystals of the monoclinic phase. The sample was heated to 
118 °C (as was done with the triclinic crystals) and then cooled to -40 °C before being 
heated to room temperature. The results are shown in Figure 3.23. The peaks around -20 
°C are once again visible, and peaks around 4 °C are now also much more prominent. This 
result confirms that the peaks previously seen in the DSC analysis are definitely related to 
the monoclinic phase. It appears to be dependent on heating of the crystals as the same 
events to do not occur if M is first cooled to -40 °C. 
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Figure 3.23. DSC results of the monoclinic phase. The sample was heated to the point where the phase 
transition from triclinic to monoclinic normally occurs, and then cooled to -40 °C. The peaks around -20 
°C are there again and the peaks around 4 °C are now much more prominent than before. 
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VT PXRD experiments further analysed this interesting result. A sample of monoclinic 
crystals were crushed to a fine powder and loaded into a glass capillary. The sample was 
equilibrated at 25 °C and a measurement was taken. Further measurements were taken at 
approximately 10 °C intervals and the sample was allowed to equilibrate for two minutes 
after each temperature increase or decrease. The sample was heated to 95 °C and then 
cooled to -45 °C. The results are shown in Figure 3.24. There are no obvious differences 
in the powder patterns of the sample at different temperatures. These patterns correspond 
well with the simulated patterns from the crystal structures at room temperature and 100 
K. 
 
When the patterns from Figure 3.24 are compared to the patterns from the experiment 
where the triclinic phase was converted to the monoclinic phase and then cooled, it is clear 
that these patterns do no match (Figure 3.25). There are peaks in the spectra in red that are 
not present in the navy spectra. DSC analysis definitely shows an event occurring at -20 
°C, so the question arises whether a phase change did in fact occur, but it was not clearly 
identified by VT PXRD analysis. 
Position [°2Theta] (Copper (Cu))
10 20 30
Counts
0
5000
0
500
0
500
0
500
0
500
0
5000
 Simulated monoclinic at RT
 Monoclinic at 25.0°C
 Monoclinic at 95.0°C
 Monoclinic at -15.0°C
 Monoclinic at -45.0°C
 Simulated monoclinic at 100 K
Figure 3.24. VT PXRD analysis of the monoclinic phase. There does not appear to be any obvious changes in 
the powder patterns at different temperatures. The simulated patterns from the crystal structures at RT and 
100 K are also included for comparison. 
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However, when results from a previous VT PXRD study of the monoclinic phase are 
compared to the results from Figure 3.24, it becomes evident that the pattern does indeed 
change. For the VT PXRD data that was previously collected, the monoclinic phase was 
heated until the sample melted. When the patterns at 125 °C are compared to the patterns 
of Figure 3.24, small differences are apparent (Figure 3.26). 
 
 
 
 
 
 
 
 
Figure 3.25. Comparison of the patterns of the triclinic sample that was converted to the monoclinic 
phase (in red), and the patterns of the experiment conducted on the monoclinic phase (in navy). 
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Figure 3.26 There is a difference in the patterns of M at 115 °C and 125 °C. The patterns at 125 °C do 
in fact correspond with the low temperature data. 
c
c
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The same single crystal X-ray diffraction studies that were performed on a triclinic crystal 
were performed on a monoclinic crystal with the aim to try and better understand what 
was happening in this system. The crystal was glued to a glass fibre as the high 
temperature would cause the crystal to move on a normal mount due to the decreasing 
viscosity of the paratone oil normally used to secure the crystal to the mount. Unit cells 
were collected at room temperature and 100 °C. Small changes were noted in the crystal 
morphology as the temperature increased. It appeared to become slightly opaque. 
Interestingly, the unit cell parameters changed from a monoclinic P cell at room 
temperature, to a monoclinic C cell at 100 °C. After the unit cell was collected, the crystal 
was cooled to 0 °C so as not to cause too much stress in the crystal, rendering it essentially 
useless. At 100 °C it was not diffracting very well. The unit cell remained monoclinic C at 
0 °C and data was collected at this temperature. Data collections were also done at -20 °C 
and -45 °C. Although the crystal diffracted well at -45 °C, a suitable space group could not 
be found. Trying to solve the data in a low symmetry class such as P1 did also not yield 
any positive results. The crystallographic data is summarised in Table 3.5. Crystal videos 
were also taken at each temperature before a data collection to track the visible changes (if 
any) in the crystal. These results are shown in Figure 3.27. 
Table 3.5 Crystallographic data for the variable temperature SCD studies of the monoclinic phase. 
Parameters RT 100 °C 0 °C -20 °C -45 °C 
Crystal system Monoclinic P Monoclinic C Monoclinic C Monoclinic C 
Monoclinic 
C or P 
Space group P21/n - C2/c C2/c - 
a (Å) 20.860(5) 31.01 30.970(3) 30.949(4) - 
b (Å) 8.085(1) 8.08 7.938(1) 7.916(1) - 
c (Å) 21.813(5) 17.37 17.159(2) 17.106(2) - 
α (°) 90 90 90 90 - 
β (°) 104.62(3) 122.97 122.880(1) 122.820(2) - 
γ (°) 90 90 90 90 - 
Z 4 - 4 4 - 
R1 ([I > 2(I)] 5.68 - 5.40 7.84 - 
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The crystal structures that were collected at 0 °C and -20 °C are both in the space group 
C2/c and the packing arrangement is remarkably different to that of the structure originally 
collected at 100 K (M100K). The asymmetric unit consists of half a cyclotriphosphazene 
molecule. Two of the fluorophenoxy rings are disordered over two positions, with 
approximately half occupancy for each position (Figure 3.28). The two disordered 
positions illustrate how the fluorophenoxy rings move at these higher temperatures (Figure 
3.29). These conformations that the rings adopt, now allow the molecules to pack in a 
higher symmetry class. 
 
 
 
 
 
 
RT 100 °C 0 °C 
-20 °C -45 °C 
Figure 3.27 Images of the changes the crystal undergoes during heating and cooling. At 100 °C 
a clear crack has formed in the crystal. At -45 °C the crystal is less clear. 
Figure 3.28 Capped stick representation of the 
monoclinic C polymorph. The two disordered 
fluorophenoxy rings are indicated in blue and green. 
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When viewed down the b-axis, the monoclinic C polymorph packs in a way that is 
reminiscent of the monoclinic P packing, viewed down the b-axis (Figure 3.30). When 
viewed down the a-axis, the cyclotriphosphazene rings all arrange in a pillar-like pattern 
along the b-axis. 
 
 
 
 
 
 
 
 
 
Figure 3.29 The different conformations the fluorophenoxy rings can 
adopt. This allows the molecules to pack in a higher symmetry class. 
Hydrogens have been omitted for clarity. 
Figure 3.30 The packing of the monoclinic C polymorph viewed down the b-axis. The blue and green 
indicate the two different disordered positions. 
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The simulated powder pattern of the monoclinic C polymorph was compared to the PXRD 
data collected on the triclinic sample. The triclinic sample was heated to the conversion 
temperature, and then cooled to -45 °C. This experiment indicated that there could be 
another phase present. The VT SCD data collected on a monoclinic crystal confirms the 
suggestion of a new phase. The PXRD results are shown in Figure 3.32. 
 
 
 
 
 
 
 
 
 
Figure 3.31 The pillar-like arrangement of the cyclotriphosphazene rings in the monoclinic C 
polymorph, viewed down the a-axis (left). The cyclotriphosphazene rings of the monoclinic P form on 
the right do not arrange in these pillars. 
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Figure 3.32 VT PXRD analysis of low temperature region after the triclinic form had been converted to 
the monoclinic phase. The simulated patterns from the crystal structures correspond well with 
experimental data collected at 5 and -20 °C. There are still differences in the pattern at -45 °C. 
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3.7. Conclusions and future work 
In this study, two novel polymorphs of hexakis(4-fluorophenoxy)cyclotriphosphazene 
were discovered and extensive analysis was performed on this system.  
The first polymorph that was identified was a conformational polymorph of 12 that 
crystallises in the triclinic crystal system. Crystals of the triclinic polymorph, T, were 
isolated from crystallisation experiments where the solvent has evaporated at a faster rate 
than the experiments that yielded the monoclinic form, M. DSC and PXRD analysis of M 
and T indicated that T converts to M at approximately 95 °C. The data also showed that it 
was not a reversible transformation, as T never reappeared on cooling. This leads to the 
conclusion that T is the metastable polymorph that converts to the more stable form M at 
higher temperatures. The endothermic conversion of T to M indicates that the two phases 
are enantiotropically related, but the reversibility of this conversion has not yet been 
observed.  
An interesting observation was made when T was heated to a point after the phase 
transformation and cooled to -60 °C: two events were observed in the DSC data at -20 °C. 
It was suspected that these events indicated another phase change in the crystal. Close 
examination of the VT PXRD data showed a change in the fine structure of the powder 
patterns, possibly indicating that a change was taking place in the crystal structure. This 
could however not be confirmed by VT SCD studies as the crystal no longer diffracted 
after the phase transformation. 
Further DSC analysis of the monoclinic form M did indicate that a phase change had 
taken place: the same events that occurred on cooling of T after the phase transformation 
occurred when M was heated to the same point and then cooled. VT SCD analysis was 
able to identify the new phase. The monoclinic P form converts to the monoclinic C 
polymorph. A lot of energy has to be introduced into the system to convert the primitive 
form to the C-centred form. The molecule has the energy to move around and twisting of 
the fluorophenoxy rings occurs. On cooling, the molecule then becomes trapped in this 
high symmetry conformation, consequently packing in the C2/c space group. Although the 
SCD data collected at -45 °C could not be solved, from numerous attempts it became clear 
that the difficulty of assigning a unit cell arose from the presence of extra reflections. 
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These reflections could be due to the crystal converting back to the monoclinic P form. 
The conversion was however not complete because the temperature was not low enough. 
This could indicate that the transformation between the monoclinic P and monoclinic C 
polymorphs is enantiotropic; therefore this could be a reversible process that occurs in a 
single crystal to single crystal fashion. In future, the crystal could be cooled to a lower 
temperature to investigate whether this allows the complete conversion from monoclinic C 
to monoclinic P. The same procedure can be followed with VT PXRD data where the 
sample could also be cooled to a lower temperature to study the peak splitting and peak 
deformation observed previously. 
Since standard temperature and pressure conditions allow for only a limited amount of 
change, pressure DSC studies could be performed on this system to investigate if a change 
in pressure could result in the identification of more polymorphs. It would also be 
interesting to investigate if different pressures could induce the same type of 
polymorphism in the other halophenoxy cyclotriphosphazene derivatives, as various 
attempts to isolate polymorphs from crystallisations with these derivatives bore no fruit. 
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Chapter 4   
Attempted co-crystal  formation with cyclotriphosphazenes  
This chapter will focus on the attempts to form co-crystals containing 
cyclotriphosphazenes. A large number of co-crystallisation experiments were conducted to 
study the conditions necessary for co-crystal and solvate formation, specifically with 
large, awkwardly shaped molecules such as cyclotriphosphazenes. These molecules 
seemed ideal for this type of study because their somewhat awkward shape could possibly 
cause inefficient packing in the solid state, leading to the formation of solvates. The range 
of substituents that can be placed on the cyclotriphosphazene ring creates the opportunity 
to incorporate various synthons into the structure to potentially form co-crystals. 
Phenyl substituents that are placed on the cyclotriphosphazene ring tend to be 
perpendicular to the nearly planar ring. Three substituents point away from the ring on 
either side. This specific shape of the cyclotriphosphazene has been shown to crystallise in 
column-like structures in the solid state.
1, 2
 Work done by Inoue and co-workers
1
 described 
the co-crystallisation of hexakis(4-carboxyphenoxy)cyclotriphosphazene and hexakis(4-
pyridylcarbinoxy)cyclotriphosphazene from DMF, where these two cyclotriphosphazenes 
arrange in columns in the solid state via hydrogen bonds between the carboxylic acid and 
pyridyl moieties. The well-known tris(o-phenylenedioxy)cyclotriphosphazene (TPP) first 
published by Allcock in 1964,
3
 exhibits the remarkable ability to include a wide variety of 
solvents,
4, 5
 methane and carbon dioxide
6
 and the ability to collect xenon atoms from the 
gas phase and subsequently orientating them on a macroscopic level.
7
 Although there are a 
few cyclotriphosphazene inclusion complexes and co-crystals present in the literature, it is 
a surprisingly small number compared to the vast amount of research conducted on 
cyclotriphosphazenes
8
 and the number of published structures in the Cambridge Structural 
Database (CSD)
9-11
. 
The aim of this study was to use the inherent properties of cyclotriphosphazene derivatives 
to form either solvates or co-crystals. These properties include the shape of the molecule, 
which is determined by the substituents on the phosphorus atoms. Therefore awkwardly 
shaped substituents where placed on the cyclotriphosphazene ring to prohibit efficient 
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packing in the crystal structure with the hope of including solvent in the crystal structure. 
Substituents containing functional groups with the potential to form supramolecular 
synthons in the solid state were used in order to engineer either pillared structures, or co-
crystals.  
First, the numerous co-crystallisation experiments conducted during this study will be 
described. The results from these experiments prompted a more in depth analysis of the 
CSD and results from this survey will be discussed. One novel co-crystal was isolated and 
the structure of this co-crystal will be described, as well as thoughts as to why this specific 
co-crystal was successfully engineered. 
4.1 Co-crystallisation experiments 
4.1.1 The trispiro and monospiro diaminoalkane cyclotriphosphazenes 
The first crystallisation experiments were carried out with the diaminoalkane series of 
cyclotriphosphazenes. The diaminoalkane chain can coordinate through both the amine 
groups, forming spirocyclic compounds with the same paddle-wheel conformation as TPP 
(Figure 4.1). TPP has shown the remarkable ability to include a wide variety of solvents 
and gases. The diaminoalkane series was therefore chosen to mimic this inclusion ability 
of TPP. Figure 4.1a shows the structure of tris(1,3-diaminopropane)cyclotriphosphazene
12
 
(7).
*
 
 
 
 
 
 
The diaminoalkane derivatives also have the potential for hydrogen bonding through the 
nitrogen atoms on the diaminoalkane chain. Derivative 7 was synthesised and co-
crystallisation experiments, as well as crystallisations from various solvents, were 
                                                 
*
 The numbering system used in this chapter follows from chapter 2. 
Figure 4.1 The crystal structures of (a) 7 and (b) TPP. Both molecules adopt a paddle wheel 
conformation. Hydrogens have been omitted for clarity. 
a) b) 
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conducted with this compound. These crystallisation experiments are listed inTable 4.1. 
The longer chain acids were chosen with the aim of forming a framework with the diacids 
acting as pillars between sheets of 7. This was however not successful. 
Table 4.1 Crystallisation experiments of 7 from different solvents and with different co-crystallisation 
agents. 
Co-crystallisation agent 
Ratio  
(7:co-former) 
Solvent system Crystallisation technique 
isophthalic acid 1:1 methanol slow evaporation 
terephthalic acid 1:2 methanol slow evaporation 
trimesic acid 1:1 methanol slow evaporation 
succinic acid 1:3 methanol slow evaporation 
maleic acid 1:3 methanol/THF slow evaporation 
tartaric acid 1:3 methanol slow evaporation 
2,6-naphthalene 
dicarboxylic acid 
1:1 methanol slow evaporation 
none - THF slow evaporation 
none - hexane/THF slow evaporation 
none - DCM slow evaporation 
none - DMSO slow evaporation 
none - acetonitrile slow evaporation 
none - methanol slow evaporation 
none - ethanol slow evaporation 
none - DMF slow evaporation 
none - NMP slow evaporation 
none - chloroform slow evaporation 
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During the investigation into co-crystal formation with 7 it was observed that if 7 was not 
used in crystallisation experiments within three days, the compound would become paste-
like and insoluble in most solvents. 
Crystals were isolated from a THF/hexane mixture. These crystals proved to be the 
hydrate of 7 that has been reported in the literature
12
 (Figure 4.2). It crystallises in the 
space group P. 
 
 
 
 
 
 
The water molecules in the structure hydrogen bond to each other in a zig-zag fashion as 
shown in Figure 4.3. This type of hydrogen bond is represented by red dotted lines. Some 
of the water molecules hydrogen bond to the nitrogen atoms of the 1,3-diaminopropane 
chain, while others hydrogen bond to the nitrogen of the cyclotriphosphazene ring. 
Hydrogen bonding also occurs between cyclotriphosphazene rings where the nitrogen of 
the 1,3-diaminopropane chain interacts with the nitrogen of the next cyclotriphosphazene 
ring. An interesting feature of the structure is the fact that two cyclotriphosphazene rings 
will only interact through the 1,3-diaminopropane chains, but the next 
cyclotriphosphazene will interact through both the nitrogen of the 1,3-diaminopropane 
chain as well as the nitrogen of the cyclotriphosphazene ring. This is shown in blue in 
Figure 4.3. This causes the molecules to pack in stacks of dimers. The molecules in a 
dimer are related to each other through a centre of inversion. 
 
 
Figure 4.2 Capped stick representation of the hydrate of 7. 
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It was surprising that no solvates were formed with hydrogen bond donating solvents such 
as methanol and ethanol. According to El Murr and co-workers,
12
 they were able to isolate 
crystals of 7 from the reaction mixture, but these crystals did not survive exposure to X-
rays. However, the crystals grown from methanol that incorporated water into the 
structure (Figure 4.2) did not disintegrate upon exposure to X-rays. Therefore, it would be 
expected that it would be beneficial to the stability of the crystal structure to incorporate 
these solvents into the crystal structure. As this does not occur, it is suspected that more 
favourable interactions are formed between molecules of 7 than between 7 and other 
molecules. In other words, homomeric crystallisation is preferred to heteromeric 
crystallisation. 
 
 
 
 
Figure 4.3 The hydrogen bonds found in the structure of 7. The red dotted lines represent hydrogen 
bonding involving water molecules. The blue dotted lines represent hydrogen bonding between 
cyclotriphosphazenes. This causes the molecules to pack in stacks of dimers. 
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4.1.2 Crystallisation experiments with 2,2-bis(4-formylphenoxy)-4,4,6,6-
bis[spiro(2,2-dioxy-1,1-biphenyl]cyclotriphosphazene (3) 
Co-crystallisation experiments were carried out with 3 (Figure 4.4) with the aim of using 
the awkward shape of the molecule to cause inefficient packing in the solid state in order 
to include solvent in the crystal structure. 3 was therefore crystallised from various 
solvents (Table 4.2). Although the aldehyde moiety is not considered to be a strong 
hydrogen bond acceptor it was co-crystallised with a wide range of hydrogen bond donors 
with the aim of forming co-crystals. The co-crystallisation experiments are listed in Table 
4.3. The ratio of 3 to co-crystal former in each case is 1:2 as 3 has two aldehyde moieties 
that can potentially participate in hydrogen bonding interactions. 
 
 
 
 
 
 
Table 4.2 Crystallisation of 3 from a range of solvents. All crystalline products were shown to be crystals of 
3. 
Solvent system Crystallisation technique Result 
benzene slow evaporation Crystals of 3 
toluene slow evaporation - 
methanol slow evaporation - 
NMP slow evaporation - 
DMSO slow evaporation - 
chloroform slow evaporation - 
acetone slow evaporation Crystals of 3 
 
N
P
N P
N
P
O
O
O
O
O
O
O
O
Figure 4.4 This molecule (3) was used in crystallisation 
experiments in the hope of forming solvates due to the 
awkward shape of the molecule. 
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Table 4.3 Co-crystallisation experiments with 3 from different solvent systems and using different 
crystallisation techniques. 
Co-crystallisation agent Solvent system Crystallisation technique 
pamoic acid THF slow evaporation 
piperazine THF slow evaporation 
2,6-diamino-pyridine THF slow evaporation, 
trimesic acid THF/hexane slow evaporation 
isophthalic acid THF/hexane layering 
benzonitrile THF layering 
2,6-diaminopyridine THF/diethyl ether vapour diffusion 
1,2-diaminoethane THF/diethyl ether vapour diffusion 
1,3-diaminopropane THF/diethyl ether vapour diffusion 
1,4-diaminobutane THF/diethyl ether vapour diffusion 
1,5-diaminopentane THF/diethyl ether vapour diffusion 
1,6-diaminohexane THF/diethyl ether Vapour diffusion 
p-aminobenzoic acid 
DCM vapour diffusion  
DMF/diethyl ether slow evaporation 
2-aminotherephthalic acid 
THF vapour diffusion  
DMF/diethyl ether slow evaporation 
2,6-dipicolinic acid THF/DCM 
vapour diffusion 
slow evaporation 
3,5-dinitrobenzoic acid 
THF vapour diffusion  
DMF/diethyl ether slow evaporation 
1,6-dihydroxynaphthalene 
THF vapour diffusion 
DMF/diethyl ether slow evaporation 
o-phenylenediamine 
THF vapour diffusion 
DMF/diethyl ether slow evaporation 
phenol 
THF vapour diffusion 
DMF/diethyl ether slow evaporation 
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Crystals were formed in a co-crystallisation with 1,6-dihydroxynaphthalene, as well as 
from benzene and acetone, and subsequent single-crystal X-ray diffraction analysis 
showed that these were crystals of pure 3. The crystal structure of 3 was described in 
chapter 2, but selected features relating to possible reasons why it did not co-crystallise 
with any small molecules will be discussed here.  
The biphenyl-2,2-diol groups in 3 adopt a conformation that is seen in both the structures 
of 2,2-dichloro-4,4,6,6-bis[spiro(2,2-dioxy-1,1-biphenylyl]cyclotriphosphazene13 (2) 
and the triply substituted tris(2,2-dioxybiphenyl)cyclotriphosphazene14 (17) (Figure 4.5). 
 
 
 
 
 
 
 
 
 
 
 
In 2 the 2,2-dioxybiphenyl groups are involved in π-π stacking interactions, causing the 
molecules to close-pack in the crystal structure despite the substituents being bulky. The 
benzaldehyde substituents of 3 also close pack by means of π-stacking interactions, 
therefore it can be concluded that these interactions (the π-stacking interactions of the 2,2-
dioxybiphenyl and the benzaldehyde groups of 3) are more favourable than forming 
Figure 4.5 The conformation of the 2,2-dioxybiphenyl groups in 3 is the same as in both structures 
of 2 and 17. 
2 17 
3 
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hydrogen bonds with donor groups such as the carboxylic acids, amines and hydroxyl 
moieties. 
The hexakis(4-hydroxyphenoxy)cyclotriphosphazene (11) was also used in co-
crystallisation experiments with acids, amines, alcohols and hydrogen bond acceptors such 
as pyridine, but no crystals could be grown from these solutions. Some of the attempted 
co-crystallisation experiments are listed in Table 4.4. All of the attempts to grow co-
crystals with hydrogen bonding being the driving force for co-crystal formation were not 
successful therefore it was decided to try to use either halogen-halogen interactions or 
halogen-nitrile interactions to construct co-crystals.  
Table 4.4 Selected co-crystallisation experiments that were attempted with 11. The ratio of 11 to the co-
crystal former is indicated, as well as the solvent system used.  
Co-crystal former Ratio Solvent system 
Crystallisation 
technique 
p-aminobenzoic acid 1:3 THF slow evaporation 
2-aminoterephthalic 
acid 
1:3 THF slow evaporation 
3,5-dinitrobenzoic acid 1:3 THF slow evaporation 
phenol 1:3 THF slow evaporation 
o-phenylene diamine 1:3 THF slow evaporation 
2,6-dipicolinic acid 1:3 DMF slow evaporation 
pyridine excess THF slow evaporation 
4,4-bipyridine 1:3 DMF slow evaporation 
4,4-trimethylene 
dipyridine 
1:3 DMF slow evaporation 
3,4-, 3,5-lutidine 1:3 DMF slow evaporation 
2,3-, 2,5- lutidine 1:3 THF slow evaporation 
2,4-, 2,6-lutidine 1:3 DMF slow evaporation 
2-, 3-, 4-picoline 1:3 THF slow evaporation 
2,6-diaminopyridine 1:3 DMF slow evaporation 
piperazine 1:3 THF slow evaporation 
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4.1.3 Attempted co-crystallisation via halogen-halogen and halogen-nitrile 
interactions 
The hexakis(4-halophenoxy)cyclotriphosphazene derivatives (12 – 15) were co-
crystallised with a range of small molecules, including molecules with halogens, nitriles 
and nitrogen-containing heterocycles such as pyridine. The solvent systems that were used 
include acetonitrile, acetonitrile/DCM, DCM, THF, THF/methanol, chloroform, 
chloroform/acetone and DMSO, as well as combinations of these solvents. 
In each case the halophenoxy cyclotriphosphazene preferred to crystallise by itself rather 
than co-crystallising with other small molecules. From these results it appears that the size 
and shape of the co-crystallisation agents do play a role. A study conducted by Anderson 
and co-workers
15
 found that molecules that crystallise with Z> 1 (more than one chemical 
unit in the asymmetric unit) are generally small, awkwardly shaped molecules. They are 
also more conformationally restricted, which would explain why the cyclotriphosphazenes 
seldom co-crystallise with smaller molecules: cyclotriphosphazenes are much larger 
molecules with substituents that are more conformationally flexible. It is therefore 
possible that the flexibility of the molecule would allow only interaction with similarly-
shaped molecules and the cyclotriphosphazene derivatives consequently crystallise 
without forming a co-crystal or inclusion compound. 
Expanding on the idea that similarly-shaped molecules would prefer to co-crystallise, the 
crystal structures of the halophenoxy derivatives 12 to 15 were analysed. It was found that 
hexakis(4-fluorophenoxy)cyclotriphosphazene (12) and hexakis(4-chlorophenoxy)-
cyclotriphosphazene (15) are isostructural (Figure 4.6), and that hexakis(4-
bromophenoxy)cyclotriphosphazene (14) and hexakis(4-iodophenoxy)cyclotri-
phosphazene (13) are isostructural (Figure 4.7). 
These structures were originally collected at room temperature
16, 17
 therefore the structures 
were recollected at 100 K.  
There are slight differences in the conformation of the chlorophenoxy rings relative to that 
of the fluorophenoxy rings, but the packing is identical when viewed down the b-axis 
(Figure 4.6). 
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Figure 4.6 The isostructural hexakis(4-fluorophenoxy)cyclotriphosphazene (12) (left, blue) and 
hexakis(4-chlorophenoxy)cyclotriphosphazene (15) (right, orange). There are slight differences in the 
conformation of the chlorophenoxy rings relative to the fluorophenoxy rings. 
12 15 
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The iodophenoxy ring of 13 is twisted relative to the bromophenoxy ring of 14 on the 
same phosphorus atom (Figure 4.7). 
 
 
Figure 4.7 The isostructural hexakis(4-iodophenoxy)cyclotriphosphazene (13) (left, purple), viewed 
down the b-axis, and hexakis(4-bromophenoxy)-cyclotriphosphazene (14) (right, maroon), viewed 
down the c-axis. One iodophenoxy ring is slightly twisted relative to the bromophenoxy ring.  
13 14 
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Unfortunately, co-crystals of 13 and 14, or 12 and 15 could not be grown from solution. It 
was decided to try to grow co-crystals by melting the isostructural compounds together. 
This was done to investigate whether there was an energy barrier that had to be overcome 
before co-crystallisation could take place. Studies that were conducted on the polymorphs 
of hexakis(4-fluorophenoxy)cyclotriphosphazene (12) in chapter three showed the effect 
temperature has on the conformation of the molecule. It was surmised that to induce co-
crystal formation, energy also had to be supplied to the system to allow the molecules to 
adapt their conformation to allow co-crystallisation with a different derivative. 
Crystals of 12 and 15 were ground together in a 1:1 ratio, melted and DSC analysis was 
performed on the product. DSC analysis showed that the melting point of the product 
(referred to as 12/15) is at 122.9 °C, which is lower than the melting point of 12 (129 °C) 
and 15 (152 °C). This is however not conclusive evidence that a co-crystal has formed, as 
melting of the one compound could possibly induce melting of the other at a lower 
temperature than expected (Figure 4.8). 
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Figure 4.8 DSC analysis of the melt product (12/15) of the fluoro and chloro derivatives. Melting 
occurs before the melting point of the fluorophenoxy derivative (129 °C).  
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The same procedure was followed for 13 and 14 (Figure 4.9) and the same observation 
was made. Once again there is only one melting point at 173.1 °C. The melting point of 14 
is at 176.8 °C and the melting point of 13 is at 187.6 °C. However, the melting point of the 
product (13/14) is again lower than both these temperatures. This could again be due to 
induced melting of 13 because of the small sample size. 
 
 
 
 
 
 
 
 
 
 
 
DSC results indicate that a co-crystal could have been formed by melting the two 
isostructural components together. This is however not conclusive evidence. PXRD 
analysis was used to further study the melt products 12/15 and 13/14. The results are 
shown in Figure 4.10 and Figure 4.11. PXRD analysis does unfortunately not deliver 
conclusive results. The powder patterns of the halophenoxy melt products 12/15 and 13/14 
largely correspond to the simulated patterns of the halophenoxy derivatives. There are 
however minor differences between the patterns, therefore it is difficult to determine 
whether a novel co-crystal has in fact formed. It could also be possible that the co-crystals 
are isostructural to the co-crystal formers, and hence have similar powder patterns. This 
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Figure 4.9 DSC analysis of the product of 13 and 14. The melting point of 13/14 is lower than that of 
both the reagents. 
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could be further analysed by solid state NMR that could indicate if new intermolecular 
interactions have formed. 
 
Figure 4.10 PXRD analysis of the melt product 12/15 of the fluorophenoxy and chlorophenoxy derivatives. 
The pattern of 12/15 corresponds with the patterns of 12 and 15 to a large extent, but the results are not 
conclusive. 
 
Figure 4.11 PXRD analysis of the melt product of 13/14 of the bromophenoxy and iodophenoxy derivatives. 
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4.1.4 Attempted mechanochemical synthesis of co-crystals 
As part of the investigation into whether energy was required to induce the formation of 
co-crystals, mechanochemical synthesis was used. The cyclotriphosphazene derivatives 2 
and 8 (Figure 4.12) were ground together with 4,4-bipyridine, imidazole and 
benzimidazole (Table 4.5). In the case of imidazole, the products of the grinding 
experiments with both 2 and 8 were sticky white substances, whereas the other products 
were fine dry powders. The products of the grinding experiments were analysed by PXRD 
and the results for the experiments conducted with 2 are shown in Figure 4.13. The results 
show that the products are mainly a mixture of the reagents, as the peaks belonging to 
each reagent can be identified in the pattern of the product. 
 
 
 
 
 
Table 4.5 The grinding experiments conducted with 2 and 8. The ratio of cyclotriphosphazene to co-crystal 
former is also indicated. 
Cyclotriphosphazene 
derivative 
Co-crystal former 
Ratio of cyclotriphosphazene: 
co-crystal former 
 
4,4-bipyridine 1:2 
imidazole 1:2 
benzimidazole 1:2 
 
4,4-bipyridine 1:4 
imidazole 1:4 
benzimidazole 1:4 
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Figure 4.12 The structure of the cyclotriphosphazene derivatives 2 and 8. 
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The results of the attempted mechanochemical synthesis between 8 and 4,4-bipyridine, 
imidazole and benzimidazole are generally the same (Figure 4.14), i.e. no co-crystals were 
formed. In the case of the reaction with benzimidazole, the product was dissolved in THF 
yielding a pink precipitate when the mixture was allowed to stand for a few days. The 
powder pattern of the precipitate differs from the powder patterns of the reagents. This is 
illustrated in Figure 4.15. 
 
 
 
 
 
 
 
Figure 4.13 The PXRD results of the mechanochemical experiments between 2 and 4,4-bipyridine, 
imidazole and benzimidazole. In most cases there appears to be an agreement between the patterns of the 
product and 4,4-bipyridine, imidazole and benzimidazole.  
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Figure 4.14 PXRD results of the grinding experiments with 8. The powder patterns of the products 
either correspond to that of 8 or the co-crystal former. 
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Figure 4.15 PXRD analysis of the precipitate formed when the product of grinding 8 and benzimidazole 
together is dissolved in THF. It is apparent that the peaks of the precipitate do not correspond with either 
of the patterns of the reagents. 
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NMR analysis of the precipitate showed numerous signals in the 
31
P spectrum that do not 
correspond with the signals normally observed for 8. This could possibly indicate that 
grinding the two components together resulted in substitution of the chloro groups with 
benzimidazole on the cyclotriphosphazene ring. It could also indicate a varying number of 
substituents, which could cause the multiple peaks seen in the spectrum (Figure 4.16). 
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Figure 4.16 The 
31
P spectrum of the pink precipitate. The peaks no longer correspond with the doublet 
and triplet usually observed for 8. 
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4.2 The co-crystal with hexakis(4-pyridyloxy)cyclotriphosphazene 
In the course of this study, more than 500 co-crystallisation experiments were carried out 
using methods such as slow evaporation, vapour diffusion, mechanochemical synthesis 
and crystallisation from the melt. One co-crystal of hexakis(4-
pyridyloxy)cyclotriphosphazene (4) with terephthalic acid was however successfully 
isolated. This is the only example of a co-crystal with this particular hexasubstituted 
cyclotriphosphazene derivative. A list of the co-crystallisation experiments that were 
conducted with 4 can be found in Table 4.6. 
The co-crystal of 4 and terephthalic acid was grown from a 1:2 ratio of 4:terephthalic acid 
in a layered solution of chloroform and DMF. Crystals of 4 were dissolved in chloroform 
and the terephthalic acid in DMF. Care had to be taken to add the two solutions together 
slowly as terephthalic acid is insoluble in chloroform and precipitates out of solution when 
chloroform is added to DMF. These two compounds co-crystallise in the space group P.  
No charge transfer has taken place in the structure, i.e. both carboxylic acid groups are 
protonated and only form hydrogen bonds with the pyridyl groups on the 
cyclotriphosphazene. The asymmetric unit contains one cyclotriphosphazene molecule and 
two and a half terephthalic acid molecules. One of the terephthalic acid molecules is on a 
special position, namely a centre of inversion, therefore only half a molecule is part of the 
asymmetric unit. This is illustrated in (Figure 4.17) where the part in green is the other 
half of the molecule that is generated by the inversion centre. 
Parameters   
Space group P 
a (Å) 7.943(4) 
b (Å) 13.238(6) 
c (Å) 23.626(1) 
α (°) 76.504(1) 
β (°) 80.357(1) 
γ (°) 85.375(1) 
Z 2 
R1 [(I > 2(I)] 3.74 
 
 
Figure 4.17 The asymmetric unit of the co-crystal of 4 and terephthalic acid along with the unit cell parameters 
and other crystallographic information. 
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Table 4.6 Co-crystallisation experiments with 4 and various diacids, amines and halophenoxy 
cyclotriphosphazene derivatives (12 – 15). The ratio of 4:co-crystal former is indicated. 
Co-crystal former Ratio Solvent 
iodopentafluorobenzene 1:2 chloroform 
bromopentafluorobenzene 1:2 chloroform 
hexakis(4-iodophenoxy)-
cyclotriphosphazene 
1:1 chloroform 
hexakis(4-bromophenoxy)-
cyclotriphosphazene 
1:1 chloroform 
trimesic acid 1:2 chloroform/THF, layered 
terephthalic acid 1:2 chloroform/DMF, layered 
fumaric acid 1:3 THF/DMF 
pamoic acid 1:3 THF/DMF 
boric acid 1:3 THF/DMF 
2-aminopyridine 1:3 THF/DMF 
urea 1:3 THF/acetonitrile, layered 
adipic acid 1:3 chloroform/DMF 
tartaric acid 1:3 chloroform/DMF 
maleic acid 1:3 chloroform/DMF 
citric acid 1:3 chloroform/DMF 
succinic acid 1:3 chloroform/DMF 
trimesic acid 1:3 chloroform/DMF, layered 
malic acid 1:3 chloroform/DMF, layered 
pamoic acid 1:3 chloroform/DMF, layered 
fumaric acid 1:3 chloroform/DMF, layered 
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Five out of the six pyridyl groups on the cyclotriphosphazene ring partakes in hydrogen 
bonding with a terephthalic acid molecule through a COOH···N interaction with the 
hydroxyl group of the carboxylic acid (Figure 4.18). This interaction causes the molecules 
to stack in an infinite hydrogen bonded chain throughout the crystal structure, alternating 
between two and three terephthalic acid molecules between each cyclotriphosphazene 
molecule (Figure 4.19). 
 
 
 
 
 
 
 
 
 
 
 
The terephthalic acid molecules shown in orange in Figure 4.20 link neighbouring chains 
by hydrogen bonding to a pyridyloxy group in the next chain.  
 
 
 
 
Figure 4.18 A capped stick representation of the five pyridyl groups each hydrogen bonding to a 
terephthalic acid molecule. 
Figure 4.19 The infinite hydrogen bonded chain. The chain alternates between two and three terephthalic 
acid molecules between each cyclotriphosphazene molecule. 
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After conducting a survey of the Cambridge Structural Database (CSD)
10, 11
, it was noted 
that this is the only example of a co-crystal with the hexasubstituted pyridyloxy derivative. 
There is however a co-crystal with a derivative very similar to 4. The only difference in 
the cyclotriphosphazene derivative is an extra carbon atom between the oxygen linker and 
the carbon atom of the phenyl ring (XUTLIH
18
), shown in Figure 4.21. In the case of this 
co-crystal, only four of the pyridylmethoxy groups each hydrogen bond to a 1,4-
anthracenedicarboxylic acid. These infinite hydrogen bonded chains are also not 
connected to each other via hydrogen bonds. 
 
 
 
 
 
 
 
Figure 4.20 The hydrogen bonded chains are linked via a terephthalic acid molecule, shown here in orange, 
that hydrogen bonds to the pyridyloxy group of a neighbouring cyclotriphosphazene molecule.  
Figure 4.21 The hydrogen bonding motif of the co-crystal of hexakis(4-pyridylmethoxy)-
cyclotriphosphazene and 1,4-anthracenedicarboxylic acid. 
Stellenbosch University http://scholar.sun.ac.za
C h a p t e r  4  –  C o - c r y s t a l  f o r m a t i o n  w i t h  c y c l o t r i p h o s p h a z e n e s  
 
24 | 4  
 
The hydrogen bond that is formed between 4 and terephthalic acid is clearly a very strong 
interaction, driving the formation of a co-crystal. It is surprising, however, that no other 
co-crystals with diacids were isolated with this derivative despite this seemingly strong 
interaction. This could indicate that the correct shape-match is very important. 
4.3 A Cambridge Structural Database survey of co-crystal occurrence with 
cyclotriphosphazenes 
The results of the investigation into co-crystal formation with cyclotriphosphazenes 
prompted another analysis of the CSD
9-11
 in order to investigate whether co-crystal 
formation with cyclotriphosphazenes is as rare an occurrence as the results implied: one 
co-crystal from 500 co-crystallisation attempts. 
First, a search was done to identify all cyclotriphosphazene derivatives in the CSD. This 
was done by drawing the base molecule as shown in Figure 4.22. The bond type is set as 
varying (indicated by dotted lines) because the cyclotriphosphazene ring has a pseudo-
aromatic character often represented in different ways. The note “T4” indicates that four 
bonds are allowed to the atom, and “T2” indicates that only 2 bonds are allowed for the 
specific atom. 
 
 
 
 
 
 
 
When the search parameters are left as unrestricted as possible, but with 3D coordinates 
determined, 682 entries that meet the search parameters are identified in the CSD. Scheme 
4.1 on the following page summarises the search process. 
N
P
N
P
N
P
T4 
T4 
T4 
T2 T2 
T2 
Figure 4.22 The cyclotriphosphazene ring is drawn in this 
way in order to identify all the cyclotriphosphazene 
derivatives. T4 implies 4 bonded atoms, and T2 implies 2 
bonded atoms, as this is a pseudo-aromatic system. 
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464 
N
P
N
P
N
P
T4 
T4 
T4 
T2 
T2 
T2 
682 
110 572 
551 21 
All cyclotriphosphazenes 
Crystals 
containing 
metals 
Excluding  
metals 
Excluding TPP 
and related 
compounds 
TPP and related 
compounds 
Scheme 4.1 This scheme outlines the CSD survey that was performed. Out of the 572 
cyclotriphosphazene crystal structures that do not contain metals, only 87 (excluding TPP) have 
more than one chemical unit. 
87 
Multicomponent 
crystals 
Single-component 
crystals 
81.1% 15.2% 
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By analysing the crystal structures in the CSD, it becomes apparent that only 18.8% of the 
cyclotriphosphazene structures contain more than one chemical entity in the crystal 
structure. Surprisingly, there are quite a number of solvates with THF, toluene, DCM and 
chloroform, although no solvates were isolated during this study. Due to the fact that TPP 
is known to be a robust inclusion compound, it was decided that TPP and its related 
derivatives could bias the search for multicomponent crystals containing 
cyclotriphosphazenes in the CSD. These structures were therefore removed from the list of 
572 structures containing cyclotriphosphazenes, resulting in 21 TPP and related structures 
being removed from the list. The remaining 551 structures were separated into structures 
containing more than one chemical unit and structures containing only one chemical unit. 
This left 87 compounds that crystallise with more than one chemical unit in the crystal 
structure. This implies that only 15.2% of the purely organic structures tend to form 
multicomponent crystals with cyclotriphosphazenes, excluding the solvates of TPP and 
related compounds. This is however a relative result, meaning that this result has to be 
compared to the occurrence of multicomponent crystals in all organic compounds. A 
search was therefore conducted for carbon and restricted to only organic compounds. 
There are a staggering 228 550 organic crystal structures in the CSD, of which 66 226 
crystallise with more than one chemical entity. This is an occurrence of 29%. The 
crystallisation of more than one chemical unit in a crystal structure is therefore quite a rare 
event, and even more so with cyclotriphosphazenes. 
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4.4 Conclusions and future work 
Co-crystal formation is not a phenomenon that often occurs, as is evident from the results 
of the CSD survey. For co-crystallisation to occur, the shape and size of the molecules 
have to match.
15
 However, shape and size similarity are not enough to induce co-
crystallisation in the case of cyclotriphosphazenes. The conformational flexibility of 
cyclotriphosphazenes can allow the molecules to adapt a conformation that favours 
interaction between cyclotriphosphazene molecules, rather than other small molecules. 
The small organic molecules used in the co-crystallisation experiments could have caused 
a shape mismatch, which would not allow co-crystallisation to occur, even though there 
was the potential for strong hydrogen bonding interaction. 
The halophenoxy cyclotriphosphazene derivatives 12 to 15 were used to study whether 
cyclotriphosphazenes with similar conformations would in fact co-crystallise. The 
derivatives 12 and 15 are isostructural, as are 13 and 14. This did however not induce co-
crystal formation from solution – in each case crystals of the pure derivative formed. An 
investigation into whether co-crystals could be grown from melting the two isostructural 
components together did not yield any conclusive results. DSC analysis showed only one 
melting point for each of the combinations, which could indicate the formation of a co-
crystal. The co-crystal would have new properties such as a different melting point from 
the parent compounds. PXRD analysis did unfortunately not shed more light on the 
situation, as it could not clearly indicate whether the patterns of 12/15 and 13/14 were 
only a mixture of the two parent components or if a new product had formed. Infrared 
spectroscopy and solid state NMR would be good analytical methods to use to further 
characterise the products of the melt. 
One novel co-crystal was synthesised and characterised in this study. Co-crystallisation 
with cyclotriphosphazenes is therefore possible, but a very strong interaction is clearly 
needed to drive the formation of the co-crystal. It is also possible that the solvent system 
plays a role in determining the pH and polarity of the solution, which could in turn 
determine how strongly a hydrogen bond donor would donate, and how strongly a 
hydrogen bond acceptor would accept. In other words, the solvent system can possibly 
determine the strength of the interaction and how favourable it is. It is interesting to note 
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that in the co-crystal of 4 with terephthalic acid, no proton transfer took place to form a 
salt.  
A computational study could aid in the understanding of interactions at play in the crystal 
structures of single-component crystals and multicomponent crystals of 
cyclotriphosphazenes. It would be useful to calculate the lattice energies of the 
cyclotriphosphazene compounds that crystallise only as a single-component crystal.
19
 This 
could be compared to calculations of the lattice energy of a co-crystal in order to 
determine whether it is more favourable (lower energy) for cyclotriphosphazenes to 
crystallise as single component crystals. If this is in fact the case, then it would go a long 
way in explaining why the occurrence of co-crystals with cyclotriphosphazenes is 
relatively low. These computational studies can aid the design process by identifying 
which properties of cyclotriphosphazenes are critical in forming supramolecular 
architectures. 
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C h ap t e r  5   
Summary and concluding remarks  
Crystal engineering is an ever-growing field of research. The crystal engineer uses 
knowledge of the vast array of intermolecular interactions available to design specific 
molecular architectures in the solid state. This study focused specifically on using 
cyclotriphosphazenes to create supramolecular architectures. The goal was to modify 
cyclotriphosphazenes with substituents that contain functional groups that could 
participate in strong supramolecular interactions in the solid state. It was hoped that the 
strong hydrogen bonding interaction, as well as other interactions such as π-π stacking, 
would direct the cyclotriphosphazene molecules to arrange in columns in the solid state. If 
these cyclotriphosphazene molecules were co-crystallised with suitable co-crystal formers, 
the co-crystal formers could play the role of linkers between the pillars essentially forming 
a framework that could potentially include solvent. Solvate formation was therefore one of 
the design aims.  
Co-crystals have been an area of intense interest for many years, especially because co-
crystallisation has such a profound effect on the properties of the parent components. The 
co-crystal often has properties that completely differ from the properties of the co-crystal 
formers. It was therefore of interest to study this phenomenon in cyclotriphosphazenes. 
Such a wide variety of substituents can be placed on the cyclotriphosphazene ring that it 
lead to the theory that the inherent variety of the cyclotriphosphazenes would be ideal for 
co-crystal formation. It was hypothesised that the substituents on the ring are reasonably 
flexible to potentially allow small changes in the conformation of the cyclotriphosphazene 
to accommodate smaller molecules in the crystal structure. The range of substituents that 
could be placed on the cyclotriphosphazene ring would allow for a diverse set of 
molecules with which to perform many co-crystallisation experiments. Extensive research 
has been conducted on the synthesis of cyclotriphosphazenes, but not in the area of using 
these molecules to construct supramolecular architectures. We therefore aimed to fill this 
apparent gap in the literature and add to the small number of co-crystal structures initially 
identified in the CSD. 
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Of the sixteen target molecules, fifteen cyclophosphazene derivatives were successfully 
synthesised in this study. Although the original aim was to synthesise derivatives with 
functional groups that could participate in hydrogen bonding, this was not successful. The 
hexakis(4-hydroxyphenoxy)-cyclotriphosphazene does in fact have this potential, but no 
co-crystals could be grown with this derivative. The greatest stumbling block in the design 
of these derivatives was the synthesis of derivatives with hydrogen bonding functionality. 
Numerous attempts were made to synthesise the hexakis(4-
carboxyphenoxy)cyclotriphosphazene, but none were successful. The most promising 
synthetic route is that of the conversion of hexakis(4-bromophenoxy)cyclotriphosphazene 
to the lithiated derivative and then converting it to the carboxylic acid through reaction 
with dry ice. This procedure has never before been attempted with cyclotriphosphazenes, 
but it is known to be highly successful with organic compounds. It would be worthwhile 
to optimise the reaction conditions by lengthening the reaction time and allowing the 
bromo derivative to react with excess nBuLi to ensure complete lithiation.  
Mechanochemical synthesis is a method that has enjoyed great popularity in recent years. 
It would therefore be worthwhile to expand attempts at generating the 
cyclotriphosphazene derivatives via mechanochemical synthesis. Results from this study 
were inconclusive regarding the success of grinding PABA and the phosphonitrilic 
chloride trimer together in the presence of base. A different base could yield better results 
and should be explored further. 
Although the occurrence of polymorphism in cyclotriphosphazenes was not part of the 
original study, a very interesting polymorphic system has been discovered. Two novel 
polymorphs of hexakis(4-fluorophenoxy)cyclotriphosphazene (12) have been identified 
and characterised with DSC, VT PXRD and SCD analyses. The original structure reported 
in the CSD crystallises in the monoclinic P system (M). The first polymorph of this 
structure that was discovered crystallised in the triclinic P system (T). The structures of 
these two polymorphs were discussed in detail in chapter 3, but the interesting feature of 
these two polymorphs is how they relate to each other. The triclinic phase undergoes an 
apparently irreversible phase transformation to the monoclinic phase at approximately 100 
°C. However, if the triclinic phase is heated to just after the phase transformation and 
cooled to sub-zero temperatures, evidence of another phase is observed. This new phase 
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does not appear once the triclinic phase has been heated past the point of conversion and 
melted. At first it was thought that this behaviour is related to the triclinic phase, as the 
same was not observed for the monoclinic phase. SCD analysis of a triclinic crystal could 
however not shed light on this phenomenon, as the crystal did not diffract past the point of 
conversion from triclinic to monoclinic.  
Fortunately, when the same experiment was conducted with a monoclinic sample (heated 
to approximately 100 °C and then cooled to -40 °C on the DSC) there was again evidence 
of another phase. SCD analysis was able to identify this phase as the crystal remained 
intact on heating to 100 °C. The new phase was a monoclinic C phase and data was 
collected at 0 °C. The molecule in this phase has higher symmetry than the monoclinic P 
molecule, although two of the fluorophenoxy rings are disordered over two positions. The 
conformation of the substituents causes the molecules to pack in such a way as to align the 
cyclotriphosphazene rings in columns in the crystal structure. Although the structure 
collected at -45 °C could not be solved, it is speculated that this could be due to a mixed 
phase present in the crystal, subsequently causing spurious reflections that make 
determining a unit cell difficult. This mixed phase possibly comprises the monoclinic P 
and monoclinic C phases. This could mean that this is in fact an example of an 
enantiotropic polymorphic system, where the monoclinic P polymorph converts to the 
monoclinic C polymorph, which in turn converts back to the monoclinic P form.  
It would be interesting to examine whether it is necessary to cool the crystal to induce the 
phase change back to monoclinic P, or if it is possible to simply leave the crystal to allow 
it to slowly convert back to the monoclinic P under ambient conditions. It would also be 
useful to conduct hot stage microscopy studies on these polymorphs.  
The Supramolecular Materials Chemistry group is now also in possession of a pressure-
DSC instrument, as well as a hot stage microscope that is connected to a DSC. This 
polymorphic system should be investigated with these instruments under conditions other 
than ambient conditions to determine whether it is possible to generate more polymorphic 
forms. The same type of study could also be done on the other halophenoxy 
cyclophosphazene derivatives, especially hexakis(4-chlorophenoxy)cyclotriphosphazene 
that is isostructural to 12. No polymorphs could be generated from crystallisations from 
solution for these halophenoxy derivatives.  
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The main focus of this study was to investigate co-crystal formation with 
cyclotriphosphazenes. This subject was extensively explored in chapter 4 and many 
conclusions can be drawn from this body of work.  
From the results of this study it appears that co-crystallisation with cyclotriphosphazenes 
does not readily occur. This could be due to the shape and size of cyclotriphosphazene 
molecules. Although the benzene-like ring and substituents that project almost 
perpendicularly from the ring are very attractive features, it has been shown that smaller 
more rigid molecules tend to have a higher occurrence of co-crystal formation. This is 
possibly due to the fact that the molecules do not have awkward shapes that need to find 
complementary co-crystal formers in order for co-crystallisation to take place. Therefore, 
the very reason for using cyclotriphosphazenes may actually be prohibiting co-crystal 
formation. 
This could however not only be a shape and size effect as there are a small number of co-
crystal structures with cyclotriphosphazenes in the CSD. The key feature in these 
structures appears to be a very strong interaction that guides the assembly of the different 
molecules. In the case of the novel hexakis(4-pyridyloxy)cyclotriphosphazene co-crystal 
with terephthalic acid that was isolated in this study, the structure is stabilised by 
hydrogen bonds between the COOH···N components of the crystal structure. This is a 
well-known supramolecular synthon that proves how strong these types of interactions are 
to overcome steric restrictions in order for heteromeric molecules to assemble in the solid 
state. 
It is evident from this study that the aggregation of cyclotriphosphazenes into 
supramolecular assemblies is highly dependent on the size and shape of the molecule itself 
and that of the co-crystal former, as well as the reaction conditions such as the solvent 
system used for co-crystallisations and the temperature at which crystallisation occurs. 
Crystal engineering therefore makes use of a variety of interactions and reaction 
conditions to create the perfect set of events to design a specific molecular assembly. This 
study further explored the field of crystal engineering with cyclotriphosphazenes and the 
role these molecules play in directing the assembly of architectures in the solid state. 
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Appendix 
Experimental  techniques  
1. Single crystal X-ray diffraction 
Cocrystal and 5Cyano –Bruker Apex DUO 
Intensity data were collected on a Bruker Apex DUO CCD diffractometer with a 
multilayer monochromator. Mo-Kα radiation (λ= 0.71073 Å) was selected for the 
experiments. The temperature of the crystal was controlled using an Oxford Cryostream 
Cooler. Data reduction was done by means of a standard procedure using the Bruker 
software package SAINT
1
 and the absorption corrections and the correction of other 
systematic errors were performed using SADABS.
2, 3
 The structures were solved by direct 
methods using SHELXS-97 and refined using SHELXL-97.
4
 X-Seed
5
 was used as the 
graphical interface for the SHELX program suite. Hydrogen atoms were placed in 
calculated positions using riding models. 
FluoroM, FluoroMrt, FluoroT, FluoroTrt, 273K, 253K, 13Iodo, 14Bromo, 15Chloro, 
7Diamino, 3Aldehyde – Bruker-Nonius SMART Apex 
X-ray intensity data were collected on a Bruker-Nonius SMART Apex diffractometer 
equipped with a fine-focus sealed tube and a 0.5 mm Monocap collimator 
(monochromated Mo-Kα radiation, λ = 0.71073 Å). Data were captured with a CCD area-
detector with the generator powered at 40 kV and 30 mA. The temperature of the crystal 
was controlled by constant stream of nitrogen gas produced by an Oxford Cryogenics 
Cryostat (700 Series Cryostream Plus). Data reduction was done by means of a standard 
procedure using the Bruker software package SAINT
1
 and the absorption corrections and 
the correction of other systematic errors were performed using SADABS.
2,3
 The structures 
were solved by direct methods using SHELXS-97 and refined using SHELXL-97.
4
 X-
Seed
5
 was used as the graphical interface for the SHELX program suite. Hydrogen atoms 
were placed in calculated positions using riding models. 
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2. Powder X-ray diffraction 
Standard PXRD 
Samples were ground to a fine powder with a mortar and pestle and placed on a zero-
background sample holder. Experiments were carried out on a PANalytical X’Pert PRO 
instrument with Bragg-Brentano geometry. Intensity data were collected using an 
X’Celerator detector and 2Ө scans in the range of 5 – 50° were performed. During the 
experiment the powdered sample was exposed to Cu-Kα radiation (λ = 1.5418 Å).  
Variable temperature PXRD 
Samples were ground to a fine powder with a mortar and pestle and sealed in a 0.3 nm 
glass capillary. The capillary spinner configuration (with focusing mirror) of the 
instrument was used along with the Oxford Cryostream Cooler for accurate temperature 
control. The sample was allowed to equilibrate for two minutes after every temperature 
change. Experiments were carried out on a PANalytical X’Pert PRO instrument with 
Bragg-Brentano geometry. Intensity data were collected using an X’Celerator detector and 
2Ө scans in the range of 5 – 50° were performed. During the experiment the sample was 
exposed to Cu-Kα radiation (λ = 1.5418 Å). 
3. Differential scanning calorimetry 
The samples (ranging from 1.5 to 3 mg) were placed in aluminium pans that were non-
hermetically sealed with vented aluminium lids. Differential scanning calorimetry was 
carried out using a TA Instruments Q100 system under a N2 gas purge, with a flow rate of 
50.0 ml/min coupled to a cooling unit. Each experiment was tailored to the type of 
analysis that was required regarding the maximum and minimum temperatures. The ramp 
rate for all experiments was 10 °C/minute to the maximum temperature. The cooling rate 
was 5 °C/minute to the minimum temperature. 
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4. Hot stage microscopy 
Hot stage microscopy was carried out on a Meiji EMZ-8TR microscope, fitted with an 
INSTEC HCS601 hot stage and an INSTEC STC200 hot stage controller. Crystalline 
samples were placed between two glass slips and heated in the range 25 – 140 °C at 10 
°C/minute. 
5. Cif files 
The cif files for all structures collected in this study can be found on the enclosed CD.  
Cif file Description 
Cocrystal The co-crystal of hexakis(4-pyridyloxy)cyclotriphosphazene and terephthalic acid. 
5Cyano The crystal structure of hexakis(4-cyanophenoxy)cyclotriphosphazene. 
FluoroM The monoclinic P phase of hexakis(4-fluorophenoxy)cyclotriphosphazene at 100 K. 
FluoroMrt The monoclinic P phase of hexakis(4-fluorophenoxy)cyclotri-phosphazene at room 
temperature. 
FluoroT The triclinic phase of hexakis(4-fluorophenoxy)cyclotriphosphazene at 100 K. 
FluoroTrt The triclinic phase of hexakis(4-fluorophenoxy)cyclotri-phosphazene at room 
temperature. 
273K The monoclinic C phase of hexakis(4-fluorophenoxy)cyclotriphosphazene at 273 K. 
253K The monoclinic C phase of hexakis(4-fluorophenoxy)cyclotriphosphazene at 253 K. 
13Iodo The crystal structure of hexakis(4-iodophenoxy)cyclotriphosphazene and 100 K. 
14Bromo The crystal structure of hexakis(4-bromophenoxy)cyclotriphosphazene at 100 K. 
15Chloro The crystal structure of hexakis(4-chlorophenoxy)cyclotriphosphazene at 100 K. 
7Diamino The structure of tris(1,3-diaminoalkane)cyclotriphosphazene hydrate. 
3Aldehyde The structure of 2,2-bis(4-formylphenoxy)-4,4,6,6-bis[spiro(2,2-dioxy-1,1-
biphenylyl]cyclotriphosphazene. 
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